CELL SEARCH SYSTEM
  Cell Name  
Cell No. Cell name General characteristics
  RCB4635     #16-15     Hybridoma cell line producing anti-human BEND3 antibody (rat IgM).  
  RCB1650     ΔAtmΔKu70-DT40     ATM and Ku70 gene double-deleted DT40 (chicken B cells).  
  RCB1651     ΔAtmΔRad54+hRad54-DT40     ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.  
  RCB1649     ΔAtm-DT40     ATM gene deleted DT40 (chicken B cells).  
  RCB1759     ΔDNAPKΔKu70-DT40     Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.  
  RCB1620     ΔDNAPK-DT40     DNA PK gene deleted DT40 (chicken B cell line).  
  RCB1749     ΔDinB-DT40     Subline of DT40 cell line, lacking DinB expression.  
  RCB1632     ΔKu70ΔRad54B-DT40     Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).  
  RCB1621     ΔKu70-DT40     Ku70 gene deleted DT40 (chicken B cell line).  
  RCB1629     ΔMre11-DT40(#190)     Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.  
  RCB1630     ΔMre11-DT40(#194)     Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.  
  RCB1747     ΔNBS1-DT40     Subline of DT40 (chicken B cell line), lacking Nbs1 expression.  
  RCB1795     ΔRad18ΔDinB-DT40     Subline of DT40 cell line, lacking both of Rad18 and DinB expression.  
  RCB1794     ΔRad18ΔXPA-DT40     Subline of DT40 cell line, lacking both of Rad18 and XPA expression.  
  RCB1750     ΔRad18-DT40     Subline of DT40 cell line, lacking Rad18 expression.  
  RCB1622     ΔRad51B-DT40     Rad51B gene deleted DT40 (chicken B cell line).  
  RCB1623     ΔRad51C-DT40     Rad51C gene deleted DT40 (chicken B cell line).  
  RCB1624     ΔRad51D-DT40     Rad51D gene deleted DT40 (chicken B cell line).  
  RCB1627     ΔRad52-DT40     Rad52 gene deleted DT40 (chicken B cell line).  
  RCB1687     ΔRad54ΔKu70-DT40     Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).  
  RCB1634     ΔRad54ΔRad54B-DT40     Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).  
  RCB1672     ΔRad54+hRad54-DT40     Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.  
  RCB1628     ΔRad54-DT40     Rad54 gene deleted DT40 (chicken B cell line).  
  RCB1764     ΔRev3-DT40     Subline of DT40 cell line, lacking Rev3 expression.  
  RCB1845     ΔUbc9+cUbc9-DT40     Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously  
  RCB1625     ΔXRCC2-DT40     XRCC2 gene deleted DT40 (chicken B cell line).  
  RCB1626     ΔXRCC3-DT40     XRCC3 gene deleted DT40 (chicken B cell line).  
  RCB1374     1-8     CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2082     103-LCL     Human B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).  
  RCB0705     10H     Anti poly(ADP-ribose) IgG3 kappa producing.  
  RCB1142     10H-2     Anti poly(ADP-ribose) IgG3 kappa producing.  
  RCB0247     10T1/2     Clone 8, Contact-inhibited semi-normal  
  RCB0998     117-13     Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell  
  RCB0870     12-1B6     Anti-human-myeloperoxidase MoAb producing.  
  AES0043     129fc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from 129/Sv female mouse. Feeder-free cell line.  
  AES0044     129fc-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from 129/Sv female mouse. Feeder-free cell line.  
  RCB1923     13D10     Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  
  RCB2083     141-LCL     Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.).  
  RCB2541     141-LCL-MUC1     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).  
  RCB0701     143B/TK^(-)neo^(R)     v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.  
  RCB0795     1B2C6     Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.  
  RCB0796     1C3D3     Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.  
  RCB0797     1C3IKEI     Human embryonic pancreas-derived cell line. See RCB0794,0795,0796.  
  RCB1922     1C7     Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  
  RCB1375     2-2     35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1376     2-7     A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  HPS0063     201B7     Human iPS cell line. HPS0002 and HPS0076 were derived from the same patient.Order Form ( C-0042, C-0034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  RCB2288     211-LCL     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616 (Deposited from Tohoku Univ.).  
  RCB1876     211-LCL-MUC1     Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615 (Deposited from Tohoku Univ.).  
  HPS0002     253G1     Human iPS cell line. HPS0063 and HPS0076 were derived from the same patient. Order Form ( C-0042, C-0034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  AES1232     26v-006     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-006.  
  AES1233     26v-009     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-009.  
  AES1240     26v-023     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-023.  
  RCB2283     277-LCL     Human B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).  
  RCB1637     293     Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.  
  RCB1668     293/CrmA     293 cell line expressing the caspase-inhibiting CrmA gene  
  RCB2202     293T     Human cell line expressing SV40 large T antigen abundantly.  
  RCB2354     293gp     Retroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.  
  RCB0794     2C6     Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.  
  RCB2709     2F8     Hybridoma producing monoclonal antibody against oxitocin receptor.  
  AES1913     2TP-084     The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID:unknown  
  AES0125     2TS22C     Mouse embryonic stem cells derived from 129/Ola male mouse. Feeder-free cell line  
  RCB0867     3-2H3     Anti-human-myeloperoxidase MoAb producing.  
  RCB0156     305M     Normal human skin fibroblast  
  RCB1145     32D     IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.  
  RCB1377     32Dcl3     Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.  
  RCB1538     32Dcl3     Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.  
  AES1384     33v1-051     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese.  
  AES1397     36v-38     The Gene-trap Mouse ES cell (V6.4) clone. Mus musculus mRNA. The NAISTrap data bese : NAISTrap_36v-38.  
  AES1421     37v-42     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_37v-42.  
  AES1519     38v-29     The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_38v-29.  
  RCB1285     3A21     Anti-ribonuclease A antibody producing.  
  RCB1642     3T3 Swiss Albino     Contact inhibition. Buck up culture of ECA2854.  
  RCB0248     3T6     Non-contact inhibited  
  RCB0289     3Y1-B cl 1-6-K5-4-2     Subclone of 3Y1-B clone 1-6.  
  RCB0290     3Y1-B clone 1     Mother clone of 3Y1 series  
  RCB0488     3Y1-B clone 1-6     Standard clone of 3Y1 series. So called 3Y1  
  RCB0288     3Y1-B clone 1-6-2     Subclone of 3Y1-B clone 1.  
  RCB0323     3Y1-SB-15     Tetraploid clone of 3Y1  
  RCB0324     3Y1-SB-16     Tetraploid clone of 3Y1  
  RCB0325     3Y1BU^(r-1)     Thymidine kinase-defective mutant of 3Y1  
  RCB0326     3Y1BU^(r-2)     Thymidine kinase-defective mutant of 3Y1  
  RCB0327     3Y1BU^(r-3)     Thymidine kinase-defective mutant of 3Y1  
  RCB0291     3Y1ts-101     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0293     3Y1ts-103     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0294     3Y1ts-104     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0295     3Y1ts-105     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0298     3Y1ts-108     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0299     3Y1ts-109     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0301     3Y1ts-111     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0304     3Y1ts-114     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0305     3Y1ts-115     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0307     3Y1ts-117     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0308     3Y1ts-118     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0310     3Y1ts-120     Temearature-sensitive mutant of 3Y1 (see library).  
  RCB0312     3Y1ts-122     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0317     3Y1ts-201     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0318     3Y1ts-202     Temperature-sensitive mutant of 3Y1 (see library).  
  RCB0296     3Y1tsA106     Temperature-sensitive mutant of 3Y1, group A  
  RCB0297     3Y1tsB107     Temperature-sensitive mutant of 3Y1, group B  
  RCB0292     3Y1tsC102     Temperature-sensitive mutant of 3Y1, group C  
  RCB0302     3Y1tsC112     Temperature-sensitive mutant of 3Y1, group C  
  RCB0303     3Y1tsC113     Temperature-sensitive mutant of 3Y1, group C  
  RCB0306     3Y1tsC116     Temperature-sensitive mutant of 3Y1, group C  
  RCB0309     3Y1tsC119     Temperature-sensitive mutant of 3Y1, group C  
  RCB0321     3Y1tsC205     Temperature-sensitive mutant of 3Y1, group C.  
  RCB0313     3Y1tsD123     Temperature-sensitive mutant of 3Y1, group D  
  RCB0314     3Y1tsD124     Temperature-sensitive mutant of 3Y1, group D  
  RCB0322     3Y1tsD206     Temperature-sensitive mutant of 3Y1, group D  
  RCB0320     3Y1tsE204     Temperature-sensitive mutant of 3Y1, group E  
  RCB0311     3Y1tsF121     Temperature-sensitive mutant of 3Y1, group F  
  RCB0316     3Y1tsF126     Temperature-sensitive mutant of 3Y1, group F  
  RCB0315     3Y1tsG125     Temperature-sensitive mutant of 3Y1, group G  
  RCB0319     3Y1tsH203     Temperature-sensitive mutant of 3Y1, group H  
  RCB0868     4-2C11     Anti-human-myeloperoxidase MoAb producing.  
  HPS0076     409B2     Human iPS cell line. HPS0002 and HPS0063 are derived from the same person. Order Form ( C-0042, C-0034).  
  RCB2843     43L     Hybrid cell line of C3H mouse mammary tumor cell, FM3A#2, and 8-Ag resistant L cell. TKG0381 (Deposited from Tohoku Univ.).  
  HPS0077     454E2     Human iPS cell line. Application consideration. Order Form ( C-0042, C-0034).  
  RCB0761     505-05-01     Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.  
  RCB3676     5637     Human cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).  
  RCB1191     5637     Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.  
  HPS0061     59M8     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  RCB2740     5A5-WASP     Hybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein). TKG0631 (Deposited from Tohoku Univ.).  
  HPS0328     606A1     Human iPS cell line derived from a healthy individual (cord blood) . Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc and Lin28 were used for establishment. Order Form ( C-0042, C-0034).  
  HPS0331     610B1     Human iPS cell line derived from a healthy individual (cord blood) . Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc and Lin28 were used for establishment. Order Form ( C-0042, C-0034).  
  RCB2352     633     Human lung cancer cell line expressing capsid protein of human adenovirus.  
  HPS0360     648A1     Human iPS cell line derived from a healthy individual (peripheral blood)l. Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc, Lin28 and shRNA against p53 were used for establishment. Order Form ( C-0042, C-0034).  
  RCB2931     6E2     Hybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.  
  RCB1190     7-TD-1     Responding to IL-6 in the bioassay.  
  RCB2282     701-LCL     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610 (Deposited from Tohoku Univ.).  
  RCB0569     707.fl     Friend leukemia cell line. High ability to differentiate to erythroblastoid cells.  
  RCB0116     7501     S. cerevisiae Endo.Sce I large subunit mAb (IgG2b)  
  RCB2811     7F9 (hybridoma)     Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.  
  RCB0171     7T1     Contact inhibited, may transform spontaneously  
  RCB2308     802C11     Hybridoma producing monoclonal antibody against MuSc.  
  RCB1909     8305C     Human thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).  
  RCB2103     8505C     Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439 (Deposited from Tohoku Univ.).  
  RCB2312     859H5     Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.  
  RCB2134     86-2     Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).  
  RCB2092     87-5     Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).  
  RCB2313     884F11     Hybridoma producing monoclonal antibody against mouse apolipoprotein E.  
  RCB0844     8C9     Producing anti-human CD36 MoAb.  
  RCB2323     9-15C     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB0869     9-1A11     Anti-human-myeloperoxidase MoAb producing.  
  RCB1517     A-6(ES derived)     Mouse ES (RCB1778 H-1) cell derived cell, useful for study of hematopoiesis.  
  RCB2128     A-THP-1     Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296 (Deposited from Tohoku Univ.).  
  GMC0037     A0001     Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0038.  
  GMC0027     A0010     Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0025.  
  GMC0021     A0022     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0016.  
  GMC0036     A0026     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00035.  
  GMC0012     A0031     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0005.  
  GMC0014     A0042     Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0015.  
  GMC0031     A0050     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0030.  
  GMC0022     A0055     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00017.  
  GMC0028     A0058     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0029.  
  GMC0004     A0065     Human primary adherent cells derived from Werner syndrome (questionable) patient's skin.  
  GMC0024     A0072     Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0020.  
  GMC0002     A0082     Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0001.  
  RCB2816     A110L     Human cell line derived from lung adenocarcinoma cells.  
  RCB3532     A129L     Human cell line derived from lung adenocarcinoma cells.  
  RCB2530     A172     Human cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).  
  RCB2745     A20     Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).  
  RCB4485     A2F10     Hybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.  
  RCB2637     A4     Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).  
  RCB0202     A431     High level of EGF receptor  
  RCB1872     A431     Human cell line derivd from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).  
  RCB2817     A529L     Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.  
  RCB0098     A549     Lung carcinoma, refer to ATCC CCL185  
  RCB3677     A549     Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184 (Deposited from Tohoku Univ.).  
  RCB0772     A6     Frog (Xenopus laevis) cell line derived from kidney.  
  RCB0344     A640-3Y1-1     3Y1 transformed with SV40 tsA640  
  RCB4481     A7R34     Hybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.  
  RCB0773     A8     Frog (Xenopus laevis) cell line derived from liver.  
  RCB3531     A904L     Human cell line derived from lung large cell carcinoma cells.  
  RCB2316     AB1     Hybridoma producing monoclonal antibody against GD1b gangliosides.  
  RCB2317     AC1     Hybridoma producing monoclonal antibody against GD1c gangliosides.  
  RCB2292     ACC-MESO-1     Human malignant pleural mesothelioma cell line.  
  RCB2293     ACC-MESO-4     Human malignant pleural mesothelioma cell line.  
  RCB4487     ACD1     Hybridoma cell line producing anti-mouse CDK4 antibody.  
  RCB4477     ACK2     Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  
  RCB4479     ACK30     Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  
  RCB4478     ACK4     Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  
  RCB4480     ACK45     Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  
  RCB0510     ACL-15     Metastasis to liver, lung  
  RCB4488     AFL4     Hybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration  
  RCB4486     AFS98     Hybridoma cell line producing anti-mouse c-fms (CD115) antibody.  
  RCB2042     AGB43     Hybridoma producing a monoclonal antibody against Sulfatide.  
  RCB2908     AH272-TC     Rat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).  
  RCB2016     AMR19     Hybridoma producing a monoclonal antibody against ganglioside lactones.  
  RCB2041     AMR20     Hybridoma producing a monoclonal antibody against GalCer.  
  RCB4482     APA5     Hybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.  
  RCB4483     APB5     Hybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.  
  RCB0447     ARLJ301-3     Diploid rat liver epithelial cell line  
  RCB0448     ARLJ301-3TR1     Spontaneous transformant of ARLJ301-3  
  RCB0002     ARM193     Anti-recA protein mAb (IgG2b)  
  RCB0115     ARM321     Anti-recA protein mAb (IgG1)  
  RCB0546     AT-PDH1TKB     Pyruvate dehydrogenase deficiency fibroblasts.  
  RCB1788     AT805     Mouse teratoma-derived cell line. Parent cell line of ATDC5.  
  RCB0565     ATDC5     Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.  
  RCB1440     ATN-1     Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).  
  RCB1437     AW-EBV-LCL     B95-8 EB virus transformed leukemia cell line.  
  RCB0331     Ad12-3Y1-W5     3Y1 transformed with adenovirus type 12  
  RCB0328     Ad12-3Y1-Z11     3Y1 transformed with adenovirus type 12  
  RCB0329     Ad12-3Y1-Z13     3Y1 transformed with adenovirus type 12  
  RCB0330     Ad12-3Y1-Z19     3Y1 transformed with adenovirus type 12  
  RCB0338     Ad2-3Y1-1     3Y1 transformed with adenovirus type 2  
  RCB0339     Ad2-3Y1-2     3Y1 transformed with adenovirus type 2.  
  RCB0340     Ad2-3Y1-3     3Y1 transformed with adenovirus type 2.  
  RCB0985     Ae     Worm cell line established by Grace. Culturable in MGM-450-10%FBS.  
  RCB0451     Anr13-1     EJ-ras oncogene transformed ARLJ301-3  
  RCB0449     Anr4     EJ-ras oncogene transformed ARLJ301-3  
  RCB0450     Anr9-1     EJ-ras oncogene transformed ARLJ301-3  
  RCB1240     Anti-α(1)1C6F4     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1243     Anti-α(4)11D9G5     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1244     Anti-α(5)11D10B6     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1246     Anti-α(7)7C9A10     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1247     Anti-α(8)9F3A6     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1248     Anti-α(9)12G8B11     MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  
  RCB1250     Anti-θ(1)3H10     MoAb to Clostridium perfringens theta-toxin.  
  RCB1239     Anti-FHA(1)1C6     Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.  
  RCB1238     Anti-FHA(2)2E9     Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.  
  RCB1208     Anti-PT-S1-10D6     Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  
  RCB1205     Anti-PT-S1-1B7     Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.  
  RCB1212     Anti-PT-S1-3F10     Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  
  RCB1214     Anti-PT-S1-4D10     Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  
  RCB1209     Anti-PT-S1-8G4     Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  
  RCB1220     Anti-PT-S2-3A12     Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.  
  RCB1222     Anti-PT-S2-9G8     Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.  
  RCB1215     Anti-PT-S23-11E6     Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.  
  RCB1223     Anti-PT-S3-7E10     Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.  
  RCB1233     Anti-PT-S4-1H2     Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.  
  RCB1229     Anti-PT-S4-7F2     Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.  
  RCB3576     Aska-SS     Human cell line derived from synovial sarcoma.  
  RCB3708     Atg3 +/+ MEFs     Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.  
  RCB3709     Atg3 -/- MEFs     Mouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.  
  RCB2710     Atg5^(+/+)MEF     Mouse embryonic fibroblasts. Wild type control for RCB2711.  
  RCB2711     Atg5^(-/-)MEF     Mouse embryonic fibroblasts lacking Atg5 gene expression.  
  RCB3706     Atg7 +/+ MEFs     Mouse embryonic fibroblasts derived from wild type mouse (C57BL/6).  
  RCB3707     Atg7 -/- MEFs     Mouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).  
  RCB4484     Avas12     Hybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.  
  GMC0003     B0006     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0025     B0010     Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0027.  
  GMC0016     B0022     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0035     B0026     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0036.  
  GMC0005     B0031     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0012.  
  GMC0023     B0036     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0015     B0042     Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0014.  
  GMC0034     B0045     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0030     B0050     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0031.  
  GMC0017     B0055     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.The same patient as GMC0022.  
  GMC0029     B0058     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. he same patient as GMC0028.  
  GMC0020     B0072     Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0024.  
  GMC0026     B0076     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0032     B0078     Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus.  
  GMC0001     B0082     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0002.  
  GMC0033     B0086     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  GMC0019     B0090     Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus.  
  GMC0013     B0096     Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  
  RCB2818     B1203L     Human cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.  
  RCB0793     B151K12     IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.  
  RCB2649     B16 F1     Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).  
  RCB2630     B16 F10     Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).  
  RCB1283     B16 melanoma     Mouse melanoma producing melanin. Application consideration  
  RCB0557     B16 melanoma 4A5     Melanin pigment producing mouse melanoma. Application consideration  
  RCB1284     B16 melanoma/lacZ     Mouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.  
  RCB2638     B16/BL6     Mouse cell line derived from melanoma.  TKG0598 (Deposited from Tohoku Univ.).  
  RCB1158     B16F10/mGM     Mouse GM-CSF producing B16 melanoma.  
  AES0172     B6-6     Mouse ES cell line derived from C57BL/6NCrSlc. Contribution to chimeras and germilne transmission have been confirmed.  
  AES0187     B6-6(feeder-free)     Mouse embryonic stem (ES) cell line derived from C57BL/6NCrSlc. Feeder-free cell line (AES0172 B6-6).  
  AES0003     B6G-2     Embryonic stem (ES) cell line derived from C57BL/6 mouse. Expressing GFP.  
  AES0143     B6J-23^(UTR)     Mouse ES cell line derived from C57BL/6J.  
  AES0140     B6J-S1^(UTR)     Mouse ES cell line derived from C57BL/6J.  
  AES0144     B6N-22^(UTR)     Mouse ES cell line derived from C57BL/6NCrlCrlj.  
  AES0141     B6NJ-22^(UTR)     Mouse ES cell line derived from F1 (C57BL/6NCrlCrlj x C57BL/6J).  
  AES0037     B6fc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  
  AES0038     B6fc-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  
  AES0035     B6ft-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  
  AES0036     B6ft-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  
  AES0033     B6mt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 male mouse. Feeder-free cell line.  
  AES0034     B6mt-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 male mouse. Feeder-free cell line.  
  RCB3530     B901L     Human cell line derived from lung adenocarcinoma cells.  
  RCB0005     BALB/3T3 clone A31     Contact-inhibited semi-normal cell line  
  RCB0256     BALL-1     Typical human B cell leukemia.  
  RCB1882     BALL-1     Human cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).  
  RCB1914     BBWV-22K3-9B     Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  
  RCB1915     BBWV-22K5-12A     Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  
  RCB1916     BBWV-22K6-2A     Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  
  RCB1716     BCAP^(-) DT40     BCAP deficient DT40 cells  
  RCB2618     BCL1-B20     Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).  
  AES0024     BCfc-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x C3H/He). Feeder-free cell line.  
  AES0022     BCft-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x C3H/He). Feeder-free cell line  
  AES0020     BCmt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x C3H/He). Feeder-free cell line  
  AES0021     BCmt-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x C3H/He). Feeder-free cell line.  
  AES0027     BD129fc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  
  AES0028     BD129fc-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  
  AES0025     BD129mt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  
  AES0026     BD129mt-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  
  AES0018     BDfc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x DBA2). Feeder-free cell line.  
  AES0017     BDft-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x DBA2). Feeder-free cell line.  
  AES0015     BDmt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x DBA2). Feeder-free cell line  
  AES0016     BDmt-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x DBA2). Feeder-free cell line.  
  AES0051     BDmto-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 (C57BL/6 x DBA2) male aged mouse. Feeder-free cell line.  
  AES0052     BDmto-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 (C57BL/6 x DBA2) male aged mouse. Feeder-free cell line.  
  RCB1423     BHK-21     The parent cell line used for the temperature sensitive cell line series of BN.  
  RCB0420     BHK-21C13-2P     Culturable in suspension, cf. ECACC ( BHK-21C13-3P).  
  RCB0423     BL312     Bovine derived lymphocyte.  
  RCB1510     BLNK^(-) DT40     BLNK deficient DT40 cells  
  RCB1704     BLNK^(-)/Syk^(-) DT40     BLNK and Syk deficient DT40 cells  
  RCB1860     BLNK^(-)Grb2^(-)DT40     BLNK and Grb2 deficient DT40 cells  
  RCB0457     BM-N     Useful for recombinant BmNPV expression. Application consideration  
  RCB2046     BMR26     Hybridoma producing a monoclonal antibody against Globoside.  
  RCB2627     BOY-12E     Human cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).  
  RCB1799     BP11(R100)     Rat (Wistar) cell line derived from renal (kidney) tumor.  
  RCB1798     BP11(R2)     Rat (Wistar) cell line derived from renal (kidney) tumor.  
  RCB1801     BP13(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1800     BP13(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1802     BP26(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1803     BP26(R80)     Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.  
  RCB1805     BP30(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1804     BP30(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1807     BP36B(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1806     BP36B(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1797     BP7(R80)     Rat renal tumor derived cell line.  
  AES0005     BRC1     Mouse embryonic stem cells derived from (B6xDBA2)x129 embryo.  
  AES0006     BRC2     Mouse embryonic stem cells derived from (B6xDBA2)x(B6xDBA2) embryo.  
  AES0007     BRC3     Mouse embryonic stem cells derived from (B6xDBA2)x(B6xDBA2) embryo.  
  AES0008     BRC4     Mouse embryonic stem cells derived from C57BL/6 embryo.  
  AES0009     BRC5     Mouse embryonic stem cells derived from C57BL/6 embryo. The karyotype is not normal.  
  AES0010     BRC6     Mouse embryonic stem cells derived from C57BL/6 embryo (female) .  
  AES0186     BRC6(feeder-free)     Mouse embryonic stem (ES) cell line derived from C57BL/6NCrSlc. Feeder-free cell line (AES0010 BRC6).  
  AES0011     BRC7     Mouse embryonic stem cells derived from C57BL/6 embryo.  
  AES0012     BRC8     Nuclear transferred mouse embryonic stem cells. Nucleus was derived from (B6xDBA2) mouse.  
  AES0013     BRC9     Nuclear transferred mouse embryonic stem cells. Nucleus was derived from (B6xDBA2) mouse.  
  RCB0804     BRF41     Zebrafish fin fibroblast. Cell growth is slow.  
  RCB0273     BRL     ES cell differentiation inhibitory activity (DIA)  
  RCB1752     BS-SHI-4M     Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.  
  RCB0205     BU25 TK-     Thymidine kinase defective HeLa  
  AES0132     BXM14     Mouse embryonic stem cells derived from F1 mouse (C57BL/6 x MSM).  
  AES0133     BXM15     Mouse embryonic stem cells derived from F1 mouse (C57BL/6 x MSM).  
  AES0130     BXM3     Mouse embryonic stem (ES) cell line derived from F1 mouse (C57BL/6 x MSM).  
  AES0131     BXM7     Mouse embryonic stem cell line derived from F1 mouse (C57BL/6 x MSM).  
  RCB4623     Ba/ER     Ba/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.  
  RCB0805     Ba/F3     IL-3 dependent pro B cell line. Conditioned medium. Information.  
  RCB4476     Ba/F3     Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information  
  RCB4474     Ba/F3-CL1     Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3). Information  
  RCB3678     BeWo     Human cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).  
  RCB1644     BeWo     It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.  
  AES0173     Bf1-Venus K/I EB3     A subline of mouse ES cell line, EB3, in which Venus gene is knocked-in in the Bf1(Foxg1) locus.  
  RCB2125     BmN4-DR     Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration  
  RCB2126     BmN4-IR     Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration  
  RCB1468     Btk^(-) DT40     Btk deficient DT40 cells  
  RCB0283     C-1300     Highly metastatic neuroblastoma  
  RCB2620     C-1300N18     Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration  
  RCB1849     C-8049     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1850     C-8052     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB0036     C127     Host for bovine papiloma virus  
  RCB0987     C2C12     Said differentiate to myotubes, but need confirmation. Backup of ECA91031101 .  
  RCB1311     C3H/HeN-emb     Mouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.  
  AES0032     C3Hfc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  
  AES0030     C3Hft-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  
  AES0031     C3Hft-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  
  AES0029     C3Hmt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He male mouse. Feeder-free cell line.  
  RCB1312     C57BL/6J-emb     Mouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.  
  RCB2854     C6     Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).  
  RCB1449     C7     p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene. Cell growth is slow.  
  RCB2819     C831L     Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.  
  RCB0988     CACO-2     Human colon carcinoma. Backup of ECA86010202 . Application consideration  
  RCB0185     CAEP     Gold fish erythrophoroma with 4n chromosomal mode  
  RCB0186     CAF     Pinna fibroblast  
  RCB4594     CALM KO MEF     CALM deficient MEF cells. Tranformed with SV40 large T antigen gene.  
  RCB4593     CALM WT MEF     CALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.      
  RCB2296     CARMA1^(-)DT40     Subline of DT40 cell line, lacking CARMA1 expression.  
  RCB2531     CB-3512     Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305 (Deposited from Tohoku Univ.).  
  RCB1911     CCD-IC     Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.  
  RCB1528     CCP-2     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1530     CCP-7     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1531     CCP-8     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1980     CCRF-CEM     Human cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).  
  RCB0016     CCRF-HSB-2     T cell leukemia  
  RCB1382     CF1TKB     Japanese cystic fibrosis fibroblast.  
  RCB0566     CGM1     EB transformed B cell line  
  RCB2809     CH12F3-2A     Mouse cell line derived from B cell lymphoma.  
  RCB0715     CHAUT-G     Smooth muscle cell sarcoma from Chinese hamster.  
  RCB0097     CHL     Widely used in chromosome aberration test  
  RCB1823     CHO·1F8     Subline of CHO-K1 that expresses human platelet activating factor receptor.  
  RCB2326     CHO-AA8     A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.  
  RCB1821     CHO-FLAG-hBLT1     Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).  
  RCB1822     CHO-HA-hBLT2     Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).  
  RCB2869     CHO-K1     A subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).  
  RCB2330     CHO-K1     Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.  
  RCB0285     CHO-K1     Widely used cell line, especially for biotechnol  
  RCB0403     CHO-K1 (SC)     CHO-K1 maintained in suspension culture.  
  RCB1477     CHO-RD     Subline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration  
  RCB0486     CHP-126     Neuroblastoma. N-myc gene amplification. Cell growth is slow. Application consideration  
  RCB0487     CHP-134     Neuroblastoma. N-myc gene amplification. Application consideration  
  RCB1034     CJM     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1035     CJM Cl4     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1036     CJM Cl5     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1037     CJM Cl6     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1038     CJM Cl7     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1039     CJM Cl8     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB0249     CKT-1     Very flat and thin kidney epithelial cell  
  RCB0266     CLA1RGB     Pseudo congenital lactic acidosis.  
  AES0166     CMES40     Embryonic stem (ES) cell line derived from common marmoset (Callithrix jacchus). Common marmoset is one of the animals as the object of Convention on International Trade in Endangered Species (CITES). Therefore, according to the CITES the permissions of the regulatory bodies are necessary in both exporting and importing countries.  
  RCB1912     CNT     Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.  
  RCB0989     COLO 679     Melanoma from a 47 year old female. Backup of ECA87061210 .  
  RCB1193     COLO-320     Described to produce serotonin, epinephrine.  
  RCB2127     COLO205     Human cell line derived from colon cancer. Derived from ascites metastasis. Cell growth is slow. TKG0457 (Deposited from Tohoku Univ.).  
  RCB0143     COS-1     SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0539     COS-7     SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2814     COS/Fucci     Subline of COS cell line expressing Fucci, a marker of cell cycle. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Important notice regarding nomenclature of Fucci.  
  RCB0990     CPAE     Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401 .  
  RCB1690     CPN4B     Cell line derived from embryo of Cynops pyrrhogaster. Cell growth is slow.  
  RCB0212     CT14-G4     Anti human c-myc p62 mAb (IgG1.kappa)  
  RCB1316     CTB-1     Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.  
  RCB0637     CTLL-2     Cytotoxic T-cell line. IL-2 dependent.  
  RCB0160     CV-1     Highly susceptible to SV40 infection. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0778     CW-2     Colon carcinoma. CEA-positive, nude mouse-transplantable.  
  RCB0471     CYNOM-K1     Cynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1947     Ca Ski     Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).  
  RCB1976     Ca9-22     Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485 (Deposited from Tohoku Univ.).  
  RCB1675     Cbl^(-) DT40     Cbl deficient DT40 cells  
  RCB4693     ChR2-C2C12     A subline of the murine C2C12 cell line (RCB0987) which stably expresses channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.  
  RCB0875     Chab1KMM     Chromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.  
  HPS0264     CiRA-PD00021     Disease specific iPS cell line derived from a patient : Parkinson's disease. Order Form (C-0042, C-0057, C-0007).  
  HPS1747     CiRA00002     Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1745 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS1745     CiRA00003     Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1747 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0327     CiRA00021     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0290 and HPS0291 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0290     CiRA00022     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0291 and HPS0327 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0291     CiRA00023     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0290 and HPS0327 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0292     CiRA00024     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0293 and HPS0294 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0293     CiRA00025     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0292 and HPS0294 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0294     CiRA00026     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0292 and HPS0293 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0376     CiRA00041     Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0377 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0377     CiRA00042     Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0376 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0378     CiRA00043     Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP). Order Form (C-0042, C-0057, C-0007).  
  HPS0383     CiRA00111     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0854, HPS0385, HPS0386 and HPS0387 were derived from the same patient.PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  
  HPS0387     CiRA00111-CKI-C2     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0386 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  
  HPS0385     CiRA00111-ES-H19     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0386 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  
  HPS0384     CiRA00111-IF-D28     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0385, HPS0386 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  
  HPS0386     CiRA00111-TKI-I15     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  
  HPS0426     CiRA00139     Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  
  HPS0429     CiRA00142     Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  
  HPS0507     CiRA00160     Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  
  HPS0508     CiRA00161     Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  
  HPS0522     CiRA00169     Disease specific iPS cell line derived from a patient :Achondroplasia. HPS0523 was derived from the same patient.  
  HPS0523     CiRA00170     Disease specific iPS cell line derived from a patient :Achondroplasia. HPS0522 was derived from the same patient.  
  HPS1746     CiRA00455     Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS0254 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS0117     CiRA086Ai-m1     Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). Application consideration. Order Form (C-0042, C-0057, C-0007).  
  HPS0119     CiRA188Ai-M1     Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0120 was derived from the same patient. Application consideration. Order Form (C-0042, C-0057, C-0007).  
  HPS0120     CiRA188Ai-W1     Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0119 was derived from the same patient. Application consideration. Order Form (C-0042, C-0057, C-0007).  
  RCB0549     Cle-H3     NIH3T3 transformant expressing human activated k-ras-2.  
  RCB0550     Cle-H3^(neo+)     pSV2neo-introduced G418-resistant Cle-H3 mutant.  
  RCB2657     Colon-26     Mouse cell line derived from colon cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).  
  RCB0644     D134     MoAb IgM to sea urchin sperm dynein alpha-heavy chain.  
  RCB0654     D16     MoAb IgG1 to sea urchin sperm dynein IC3.  
  RCB0646     D264     MoAb IgM to sea urchin sperm dynein beta-heavy chain.  
  RCB0648     D308     MoAb IgM to sea urchin sperm dynein beta-heavy chain.  
  RCB2648     D4     A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). Cell growth is slow. TKG0300 (Deposited from Tohoku Univ.).  
  RCB0649     D52     MoAb IgM to sea urchin sperm dynein IC1.  
  RCB0651     D58     MoAb IgG1 to sea urchin sperm dynein IC2.  
  RCB0650     D9     MoAb IgM to sea urchin sperm dynein IC2.  
  RCB2105     D98-AH2     Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).  
  RCB1143     DA-1     IL-3 dependent mouse myeloid cells. MoLV induced.  
  RCB1144     DA-3     IL-3 dependent mouse myeloid cells. MoLV induced.  
  RCB1857     DA-3 (hybridoma)     Hybridoma producing a monoclonal antibody against domoic acid.  
  RCB1640     DAUDI     Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.  
  AES0041     DBAfc-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 female mouse. Feeder-free cell line.  
  AES0042     DBAfc-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 female mouse. Feeder-free cell line.  
  AES0039     DBAmt-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 male mouse. Feeder-free cell line.  
  AES0040     DBAmt-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 male mouse. Feeder-free cell line.  
  RCB0473     DD762     Mammary tumor cell line without C-type virus  
  RCB2831     DEOC-1     Human cell line derived from malignant melanoma. Cell growth is slow.  
  RCB1604     DHA3-1     Mouse T cell hybridoma expressing double HA-tag alone.  
  RCB1605     DHA3-26     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1608     DHA9-13     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  
  RCB1609     DHA9-15     Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1607     DHA9-3     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  
  RCB2945     DIT29     Medaka cell line derived from hepatoma cells.  
  RCB0736     DJM-1     Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.  
  RCB1606     DMyc3-45     Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .  
  RCB1610     DMyc9-36     Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1464     DT40     Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.  
  RCB1851     DT40 Cre1     A subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).  
  RCB1817     DT40(v-myb^+)WT     A subline of avian cell line, DT40, expressing v-myb exogenously.  
  RCB1818     DT40(v-myb^+)Δpolβ     A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.  
  RCB1820     DT40(v-myb^+)Δpolβλ     A subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.  
  RCB1819     DT40(v-myb^+)Δpolλ     A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.  
  RCB2143     DU145     Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).  
  AES0161     Dnmt1-/- ES (clone 36)     Mouse ES cell line lacking Dnmt gene.  
  AES0146     Dnmt1-/-Dnmt3a-/-Dnmt3b-/- ES (clone19)     Mouse ES cell line lacking all of Dnmt1, Dnmt3a and Dnmt3b. Derived from 129Sv/Jae.  
  AES0164     Dnmt3a-/- ES (clone 6aa)     Mouse ES cell line lacking Dnmt3a gene.  
  AES0165     Dnmt3b-/- ES (clone 8bb)     Mouse ES cell line lacking Dnmt3b gene.  
  RCB0096     Don(D-6)     Pseudodiploid, two marker chromosomes  
  AES0135     E14tg2a     Mouse embryonic stem (ES) cell line derived from 29/Ola.  
  RCB0332     E1A-3Y1-1     3Y1 transformed with adenovirus type 12 E1A gene  
  RCB0333     E1A-3Y1-2     3Y1 transformed with adenovirus type 12 E1A gene.  
  RCB0334     E1A-3Y1-3     3Y1 transformed with adenovirus type 12 E1A gene.  
  AES0139     EB3     Mouse embryonic stem cell line derived from 129/Ola strain. Oct3/4 gene was replaced with 'ires-blasticidin S registant gene' in one allele. Feeder-free cell line. Feeder-free cell line.  
  AES0151     EB5     Mouse embryonic stem cell line derived from 129/Ola. Feeder-free cell line.  
  RCB1965     EBC-1     Human lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).  
  AES0054     EBRTcH3     Mouse embryonic stem cell line. Convenient to establish the line carrying an inducible expression unit (see reference). Feeder-free cell line.  
  AES0119     EBRTcH3(serum)     Mouse embryonic stem (ES) cell line derived from 129/Ola mouse. Feeder-free cell line  
  RCB0774     EC-GI-10     Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.  
  RCB0983     ECC10     Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.  
  RCB1009     ECC12     Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. Application consideration  
  RCB0982     ECC4     Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.  
  RCB1286     ECPC-3     Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.  
  RCB1287     ECPC-4     Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape  
  RCB2345     EEB     Human cell line derived from erythroblastic leukemia.  
  AES0134     EGFP-MBD-nls     Mouse embryonic stem cells derived from 129/Ola male mouse. The methylated DNA binding domain (MBD) and the nuclear localization signal (nls) sequence coding for human methyl CpG-binding domain protein 1 (MBD1) were fused to the enhanced green fluorescent protein (EGFP) reporter gene, and ES cell lines carrying the construct ( EGFP-MBD-nls ) were established. Feeder-free cell line  
  AES0184     EGR-101     Mouse embryonic stem (ES) cell line derived from C57BL/6N.  
  AES0182     EGR-G101     Mouse embryonic stem (ES) cell line derived from C57BL/6NCr. Expressing EGFP.   
  RCB2150     EKOP     Subline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.  
  RCB1641     EL4     9,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.  
  RCB2327     EM-9     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.  
  RCB1847     ES-8040 20-2     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1848     ES-8047 2-1     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB0142     Ehrlich     Ehrlich's ascite tumor  
  RCB0641     EoL-1 cell     Eosinophilic leukemia. Differenciate by n-butylate treatment.  
  AES0204     EpiSC 129Ba1     Mouse Epiblast Stem cells (EpiSCs) established in the presence of Wnt secretion inhibitor, IWP-2. The cell line was derived from embryos obtained by 129S2/Sv x C57BL/6N cross. Homogeneous cellular state can be maintained in the culture medium containing IWP-2.  
  AES0176     Etv2-Venus-KI     Mouse embryonic stem (ES) cell line, Etv2-Venus-KI (see reference).  
  AES0177     Etv2-Venus-KO     Mouse embryonic stem (ES) cell line, Etv2-Venus-KO (see reference).  
  RCB0776     F-36E     Subline of F-36P. Erythropoietin-dependent  
  RCB0775     F-36P     GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.  
  RCB0560     F5-5.fl     Friend leukemia. Differentiate to erythroblastoid cells with benzidine etc.  
  RCB2643     F9     Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration  
  RCB1555     F9     Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.  
  RCB2315     F9/LM(1+10)     Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.  
  RCB2314     F9/LM10     Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.  
  RCB0783     FCP-S1M     Skin fibroblasts from a familial colon polyposis patient.  
  RCB0784     FCP-S2H     Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  
  RCB0785     FCP-S3H     Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  
  RCB0786     FCP-S4H     Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  
  RCB0787     FCP-S5H     Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  
  RCB0788     FCP-S6H     Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  
  RCB2610     FELV3281-AD     Cat cell line derived from lymphoma.  
  RCB4452     FL-YB     Mouse follicular dendritic cell line  
  RCB0086     FM3A     Mammary carcinoma, grow in vitro and in vivo  
  RCB0032     FM3A FT-101     Temperature-sensitive, forms multiple nuclei  
  RCB0034     FM3A ts T244     Temperature-sensitive at DNA polymerase  
  RCB0033     FM3A tscl.T85 Tsai     Temperature-sensitive at chromosome condensation  
  RCB1495     FU-RPNT-1     Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration  
  RCB2078     FU-RPNT-2     Human primitive neuroectodermal tumor cell line derived from kidney.  
  AES0045     FVB-1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from FVB male mouse. Feeder-free cell line.  
  RCB0571     FVTCT.fl     Friend leukemia cell line from BALB/c mouse. Virusnon-producing.  
  AES0120     Fbx15^(βgeo/βgeo)ES     A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse) lacking Fbx15 expression. Fbx15 gene was replaced with βgeo gene in both alleles.  
  RCB0764     Fvp^(r)B350     Topoisomerase II inhibitor VP-16 resistant FM3A mutant.  
  RCB0991     G-361     Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401 .  
  RCB2640     G-415     Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).  
  RCB1652     G1MF285D     Hybridoma that produce anti-human G1MF (allotype of IgG1) antibody.  
  AES0150     G4-2     Mouse embryonic stem (ES) cell line derived from 29/Ola. Expressing GFP.  
  RCB0555     GCIY     Stomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.  
  RCB1709     GE1     Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration  
  RCB1175     GEM-199     Tumor cells derived from Gold Fish red pigment cells.  
  RCB1176     GEM-218     Tumor cells derived from Gold Fish red pigment cells.  
  RCB1174     GEM-81     Tumor cells derived from Gold Fish red pigment cells.  
  RCB2021     GGR41     Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.  
  RCB0763     GI-1     Human glioma separated from gliosarcoma.  
  RCB0697     GM2-1TKB     Tay-Sachs' disease  
  RCB0570     GM86.fl     Friend leukemia cell line from DBA/2 mouse.  
  RCB1026     GM95     Glucosylceramide synthetase-deficient B16 melanoma mutant.  
  RCB2014     GMB7     Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).  
  RCB2013     GMR3     Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).  
  RCB2015     GMR8     Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).  
  RCB0721     GOTO·P3     Subline of GOTO. Protein-free medium adapted. Cell growth is slow.  
  RCB1182     GR-ST     RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.  
  RCB1865     GRP1^(-)/GRP3^(-)DT40     Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.  
  RCB1863     GRP1^(-)DT40     Ras GRP1 deficient DT40 cells  
  RCB1864     GRP3^(-)DT40     Subline of DT40 cell line, lacking RasGRP3 expression.  
  AES0002     GS-DG1     Germline stem cell line derived from mouse testis.  
  RCB1681     GS-HepG2     A subline of HepG2. Expressing abundant glutamine synthetase. Information  
  RCB2277     GSS     Human gastric cancer cell line derived from metastasis at liver.  
  RCB2278     GSU     Human cell line derived from gastric cancer. Established from the cells in ascites.  
  RCB1858     GT-13A (hybridoma)     Hybridoma producing a monoclonal antibody against gonyautoxin.  
  RCB1498     Grap^(-) DT40     Grap deficient DT40 cells  
  RCB1499     Grb2^(-) DT40     Grb2 deficient DT40 cells  
  RCB1836     Grb2^(-)/Grap^(-) DT40     Grb2and Grap deficient DT40 cells  
  AES0001     H-1     In vitro differentiation to various type tissue cells(e.g. neuron,cardiomyocyte,hematopoietic cells)  
  RCB1884     H-111-TC     Human cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.). Cell growth is slow.  
  RCB1011     H-AE-IV     Anencephalous embryonic fibroblast.  
  RCB0508     H-EMC-SS     Extraskeletal myxoid chondrosarcoma  
  RCB2997     H414     Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).  
  RCB3002     H414-LIG4(+/-)     Subline of H414 cell line lacking Ligase 4 gene in one allele.  
  RCB3000     H414-MDC1(+/-)     Subline of H414 cell line lacking MDC1 gene in one allele.  
  RCB3001     H414-MDC1(-/-)     Subline of H414 cell line lacking MDC1 gene in both alleles.  
  RCB2998     H414-RAD18(+/-)     Subline of H414 cell line lacking RAD18 gene in one allele.  
  RCB2999     H414-RAD18(-/-)     Subline of H414 cell line lacking RAD18 gene in both alleles.  
  RCB0540     HAL-01     Acute lymphatic leukemia  
  RCB2280     HCE-T     SV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium.  
  RCB2979     HCT116     Human cell line derived from colon cancer. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB4662     HCT116 CMV-OsTIR1     This is an HCT116 cell line in which CMV-OsTIR1 (pMK232, PURO) was introduced at the both alleles of the AAVS1 locus by using CRISPR/Cas.This parental cell line consitutively express OsTIR1 and can be used for generation of AID mutants.  
  RCB2996     HCT116-53BP1(+/-)     Subline of HCT116 cell line lacking 53BPI gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2984     HCT116-ARTEMIS(+/-)     Subline of HCT116 cell line lacking ARTEMIS gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2985     HCT116-ARTEMIS(-/-)     Subline of HCT116 cell line lacking ARTEMIS gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2992     HCT116-DNAPKcs(+/-)     Subline of HCT116 cell line lacking DNAPKcs gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2991     HCT116-KU70(+/-)     Subline of HCT116 cell line lacking Ku70 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2994     HCT116-LIG3(+/-)     Subline of HCT116 cell line lacking Ligase 3 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2995     HCT116-LIG4(+/-)     Subline of HCT116 cell line lacking Ligase 4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2986     HCT116-MDC1(+/-)     Subline of HCT116 cell line lacking MDC1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2987     HCT116-MDC1(-/-)     Subline of HCT116 cell line lacking MDC1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2993     HCT116-POLM(+/-)     Subline of HCT116 cell line lacking DNA polymerase m gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2982     HCT116-RAD18(+/-)     Subline of HCT116 cell line lacking RAD18 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2983     HCT116-RAD18(-/-)     Subline of HCT116 cell line lacking RAD18 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2988     HCT116-REV1(+/-)     Subline of HCT116 cell line lacking REV1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2989     HCT116-REV1(-/-)     Subline of HCT116 cell line lacking REV1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2990     HCT116-REV3L(+/-)     Subline of HCT116 cell line lacking REV3L gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2980     HCT116-XRCC4(+/-)     Subline of HCT116 cell line lacking XRCC4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2981     HCT116-XRCC4(-/-)     Subline of HCT116 cell line lacking XRCC4 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB1981     HD-Mar2     Human cell line derived from Hodgkin's lymphoma. TKG0198 (Deposited from Tohoku Univ.).  
  RCB0679     HDC     Mother of a Down's syndrome child. 46XX,t(2/q2/q)  
  RCB2233     HE12     Human fibroblast-like cells derived from embryo. Not immortalized. Application consideration  
  RCB2234     HE13     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2237     HE16     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2238     HE18     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2239     HE19     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2240     HE21     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2241     HE22     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2244     HE27     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2245     HE28     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2246     HE29     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2247     HE30     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2248     HE31     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2249     HE32     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2250     HE33     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2251     HE34     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2254     HE36     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2256     HE37     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2257     HE38     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2258     HE39     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2259     HE40     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2260     HE41     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2261     HE42     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2262     HE46     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2263     HE47     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2264     HE48     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2265     HE49     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2266     HE50     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2267     HE51     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2268     HE52     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2269     HE53     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2270     HE54     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2271     HE55     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB2273     HE57     Human fibroblast-like cells derived from embryo. Not immortalized.  
  RCB1889     HEp-2     Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).  
  RCB0708     HF10B4     Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.  
  RCB0210     HF19     Normal human lung fibroblast.  
  RCB0524     HFL-AE-I     Human lung fibroblasts derived from anencephalous embryo.  
  RCB0525     HFL-AE-II     Human lung fibroblasts derived from anencephalous embryo.  
  RCB0684     HFL-AE-III     Human lung fibroblasts derived from anencephalous embryo.  
  RCB1613     HFL-AE-VI     Human lung fibroblasts derived from anencephalous embryo.  
  RCB1617     HFL-AE-VII     Human lung fibroblasts derived from anencephalous embryo. RCB1615 and RCB1618 are derived from the same embryo.  
  RCB0521     HFL-I     Normal embryonic lung fibroblast  
  RCB0522     HFL-II     Normal embryonic lung fibroblast  
  RCB0523     HFL-III     Normal embryonic lung fibroblast  
  RCB1541     HFL9t     47, +del(9)(q12) chromosome, the same patient as RCB1542.  
  RCB1618     HFLI-AE-VII     Human liver fibroblasts derived from anencephalous embryo. RCB1615 and RCB1617 are derived from the same embryo.  
  RCB1542     HFSK9t     47, +del(9)(q12) chromosome, the same patient as RCB1541.  
  RCB1139     HFSKF-AE-V     Human skin fibroblasts from embryo.  
  RCB1615     HFSKF-AE-VII     Human skin fibroblasts derived from anencephalous embryo. RCB1617 and RCB1618 are derived from the same embryo.  
  RCB0698     HFSKF-II     Normal human fetal skin fibroblast.  
  RCB0665     HFWT     Wilms' tumor. CA125 and TPA producing.  
  RCB0500     HGC-27     Gastric cancer undifferentiated, mucin producing  
  RCB0966     HGRT     Benign mature tridermal teratoma.  
  RCB0959     HH13-1     Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.  
  RCB0960     HH17-4     Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.  
  RCB0658     HHUA     Expressing receptor to estrogen and progesterone. Cell growth is slow.  
  RCB0978     HIRS-BM     Mixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.  
  RCB0820     HKBML     Human brain derived lymphoma. Epstein-Barr virus positive.  
  RCB0680     HKBMM     Human malignant meningioma.  
  RCB2253     HKb20     Subline of HEK293 cell line, expressing BtR175b (Cry 1Aa receptor).  
  RCB3683     HL-60     Human cell line derived from promyelocytic leukemia cells. TKG0345 (Deposited from Tohoku Univ.).  
  RCB1550     HL-60-R2     Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.  
  RCB0041     HL60     Differentiate to granulocytes and monocytes  
  RCB0083     HLC-1     Lung adenocarcinoma  
  RCB2358     HLtat     A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.  
  RCB0819     HMMME     Human malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.  
  RCB0777     HMV-II     Melanin producing. Originated from the same site of HMV-I.  
  RCB3685     HMV-II     Human cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).  
  RCB0591     HNS1A     Salamander cell line with large chromosomes. Cell growth is slow.  
  RCB0592     HNS2     Larger epithelial cells than HNS1A.  
  RCB0593     HNS3     Salamander cell line. Fibroblast-like cells.  
  RCB0594     HNS4     Salamander cell line. Epithelial-like cells.  
  RCB0595     HNS5     Salamander cell line. Fibroblast-like cells. Cell growth is slow.  
  RCB1296     HNT-34     AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. Application consideration  
  RCB2102     HO-1-u-1     Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).  
  RCB1514     HOCE     Japanese choriocarcinoma cell line. Cell growth is slow. Application consideration  
  RCB1010     HOEF     Endometrium-derived fibroblasts.  
  RCB0657     HOKUG     Glassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.  
  RCB1513     HOMM     Melanoma cells with melanin-granules. Cell growth is slow.  
  RCB0992     HOS     Sensitive to further transformation with both virus and chemicals. Backup of ECA87070202 .  
  RCB0662     HOTHC     Thyroid tumor. TAF, G-CSF, colloid producing.  
  RCB0690     HOTHC-SF     Serum-free, protein-free cultured HOTHC cells  
  RCB0659     HOUA-I     Poorly differentiated adenocarcinoma. Cell growth is slow.  
  RCB1171     HOUFXXX     47,XX,+X-type chromosome.  
  RCB0769     HP100-1     Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.  
  RCB0768     HP50-2     Hydrogen peroxide resistant HL60-derived clone.  
  RCB1935     HPB-ALL     Human cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).  
  RCB0356     HR-3Y1-1     3Y1 transformed with v-Ha-ras oncogene  
  RCB0357     HR-3Y1-2     3Y1 transformed with v-Ha-ras oncogene  
  RCB1294     HRC-17     Hybridoma producing anti-E antigen of the human Rh blood group system  
  RCB2364     HS-ES-1     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.  
  RCB2360     HS-ES-2M     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  
  RCB2361     HS-ES-2R     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  
  RCB0159     HS-K     Normal diploid fibroblast from Japanese  
  RCB2229     HS-Os-1     Human cell line derived from osteosarcoma.  
  RCB1757     HS-P     Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.  
  RCB2362     HS-PSS     Human cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2231     HS-SY-II     Human cell line derived from synovial sarcoma. Application consideration  
  RCB2230     HS-Sch-2     Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).  
  RCB1945     HSC-2     Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).  
  RCB1975     HSC-3     Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).  
  RCB1902     HSC-4     Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).  
  RCB1846     HSC-F     T cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0515     HSKTC     Krukenberg tumor cell line  
  RCB0666     HSNB     N-myc propagated. Neuron specific enolase producing.Application consideration  
  AES0128     HSNT1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (Hematopoietic stem cell) was derived from F1 (C57BL/6 x 129) male mouse.  
  AES0129     HSNT2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (Hematopoietic stem cell) was derived from F1 (C57BL/6 x 129) male mouse.  
  RCB1854     HSP-239     T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1855     HSP-250     T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0789     HSQ-89     Japanese maxillary simus squamous carcinoma  
  RCB0452     HTC/C3     Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin  
  RCB0700     HTMM     Malignant melanoma from lympho node.  
  RCB0660     HTMMT     Mixed Mullerian tumor.  
  RCB0967     HTST     Human sacrococcygeal teratoma.  
  RCB0713     HTUD1     Large cells with large chromosomes.  
  RCB0153     HUC-F     Normal umbilical cord fibroblast, female  
  RCB0436     HUC-F2     Normal umbilical card fibroblast, female  
  RCB0197     HUC-Fm     Normal umbilical cord fibroblast, male  
  RCB0437     HUC-Fm2     Normal umbilical cord fibroblast, male  
  RCB1934     HUT78     Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375 (Deposited from Tohoku Univ.).  
  RCB1297     HYT-1     Human acute myeloid leukemia derived cell.  
  RCB0411     HaP-T1     Mucin producing, BHP-induced pancreatic tumor  
  RCB0476     Had-1     Newcastle disease virus resistant  
  RCB2076     Has     Chinese hamster cell line. Epithelial-like adherent cells.  
  RCB0007     HeLa     Just like ATCC CCL 2, HeLa  
  RCB3680     HeLa     Human cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).  
  RCB2355     HeLa CD4+Clone1022     A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.  
  RCB3682     HeLa S3     Human cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).  
  RCB0271     HeLa S3 (SC)     Suspension culturable. Useful for JIS medium inspection  
  RCB1891     HeLa TG     A subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).  
  RCB0402     HeLa·P3     Protein- & lipid-free medium growing  
  RCB2356     HeLa-CD4-LTR-β-gal     A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.  
  RCB3681     HeLa.P3(S)     Subline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).  
  RCB1525     HeLa.S3     = RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.  
  RCB0191     HeLa.S3     Most famous cultured human cell line  
  RCB0503     HeLa.S3(Mer^(-))     Repair deficient (mer~)  
  RCB2812     HeLa/Fucci     A subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4. Important notice regarding nomenclature of Fucci.  
  RCB4676     HeLa/Fucci(CA)2     A subline of the HeLa cell line expressing FucciCA, a cell cycle marker. Important notice regarding nomenclature of Fucci.  
  RCB2867     HeLa/Fucci2     A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.  
  RCB1886     Hep G2     Human cell line derived from hepatocyte carcinoma. TKG0205 (Deposited from Tohoku Univ.). Information  
  RCB1648     Hep G2     hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870. Almost equal to RCB0459, but the restriction is a. Information  
  RCB1638     Hepa 1-6     Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.  
  RCB1155     Hepa-E1     Eel hepatocyte. Application consideration  
  HPS0029     HiPS-RIKEN-12A     Human iPS cell line. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0003     HiPS-RIKEN-1A     Human iPS cell line. Parent cell line of RCB0436 HUC-F2. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0009     HiPS-RIKEN-2A     Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0014     HiPS-RIKEN-2F     Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0045     HiPS-RIKEN-5A     Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0395 NCU-F8). Order Form (C-0042, C-0006, C-0007 or C-0007p).  
  HPS0049     HiPS-RIKEN-7A     Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0390 NCU-F3). Order Form (C-0042, C-0006, C-0007 or C-0007p).  
  HPS0053     HiPS-RIKEN-9A     Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0391 NCU-F4). Order Form (C-0042, C-0006, C-0007 or C-0007p).  
  RCB1728     Hpr-4     H2O2 resistant Chinese Hamster V79 cells  
  RCB1960     HuCCT1     Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).  
  RCB1179     HuG1-N     Stomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.  
  RCB1178     HuG1-PI     Stomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.  
  RCB1943     HuH-28     Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).  
  RCB1367     HuH-6     Hepatoblastoma. Said albumin and alpha-fetoprotein producing.  
  RCB1366     HuH-7     Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.  
  RCB1942     HuH-7     Human cell line derived from hepatoma. TKG0206 (Deposited from Tohoku Univ.).  
  RCB2532     HuO 9N2 (O9N2)     Human cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).  
  RCB2104     HuO-3N1     Human cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).  
  RCB0711     HyGPD·YK-1-1     Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.  
  RCB0709     HyLDH·YK-1     Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.  
  RCB0710     HyLDH·YK-2     Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium  
  RCB0548     IA-5     Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic assay.  
  RCB0554     IA-LM     Japanese lung large cell carcinoma  
  RCB0102     IC-2     Mast cell precursor, respond to IL-3. Conditioned medium.  
  AES0049     ICRft-2     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from ICR male mouse. Feeder-free cell line.  
  RCB0993     IEC 6     Rat small intestine epithelial cells. Backup of ECA88071401 .  
  RCB2093     II-18     Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).  
  RCB0475     ILT-Mat     IL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).  
  RCB1024     IMR-90-SV     SV40 transformed human lung fibroblast.  
  RCB4472     IN-IC     Rat cell line derived from kidney.  
  RCB1717     IP3R type1^(-)/2^(-) DT40     IP3R type1 and IP3R type2 deficient DT40 cells  
  RCB1718     IP3R type1^(-)/3^(-) DT40     IP3R type1 and IP3R type3 deficient DT40 cells  
  RCB1719     IP3R type2^(-)/3^(-) DT40     IP3R type2and IP3R type3 deficient DT40  
  RCB1467     IP3R^(-) DT40     IP3R(type1,type2,type3) deficient DT40 cells  
  RCB1918     J#176-3.2     Hybridoma producing a monoclonal antibody against mouse JDP2.  
  RCB1919     J#214.2-2     Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.  
  RCB1920     J#249.1-1     Hybridoma producing a monoclonal antibody against mouse JDP2.  
  RCB2652     J774-1     Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).  
  RCB0434     J774.1     Macrophage-like cell  
  RCB2309     JFP-J1     Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  
  RCB2310     JFP-J5     Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  
  RCB2311     JFP-K2     Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  
  RCB1705     JHCA-ov     Human colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Application consideration  
  RCB1706     JHCOLOYI     Human cell line derived from rectal cancer. Application consideration  
  RCB1520     JHOC-5     Clear cell adenocarcinoma. Said CA125, CA72-4 producing. Application consideration  
  RCB1688     JHOC-7     Human ovary clear cell carcinoma cell line. Application consideration  
  RCB1723     JHOC-8     Human ovary clear cell carcinoma cell line. Application consideration  
  RCB2226     JHOC-9     Human cell line derived from ovary cancer. Clear cell carcinoma. Application consideration  
  RCB1676     JHOM-1     Human ovary mucinous adenocarcinoma cell line. Application consideration  
  RCB1682     JHOM-2B     Human ovary mucinous tubular adenocarcinoma cell line. Application consideration  
  RCB2365     JHONA     Human cell line derived from ovarian squamous cell cancer. Application consideration  
  RCB1521     JHOS-2     Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. Application consideration  
  RCB1546     JHOS-3     Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. Application consideration  
  RCB1678     JHOS-4     Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. Application consideration  
  RCB1724     JHSK-rec     Human rectal cancer cell line. Application consideration  
  RCB1543     JHTKI-col-L     B lymphocytes isolated from a colon adenocarcinoma.  
  RCB1708     JHTSK-col-L     Human B cell-like cell line derived from colon adenocarcinoma tisuue.  
  RCB1544     JHUAS-1     Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow. Application consideration  
  RCB1545     JHUAS-2-L     B lymphocyte isolated from Japanese adenosquamous carcinoma.  
  RCB1547     JHUCS-1     Japanese uterine carcinosarcoma. Nude mouse transplantable. Application consideration  
  RCB1721     JHUCS-3     Human cervical cancer cell line. Application consideration  
  RCB1548     JHUEM-1     Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing. Application consideration  
  RCB2225     JHUEM-14     Human cell line derived from uterus cancer. Endometrioid adenocarcinoma. Application consideration  
  RCB1551     JHUEM-2     Japanese endometrioid adenocarcinoma. Application consideration  
  RCB1552     JHUEM-3     Human uterus endometrioid adenocarcinoma cell line. Application consideration  
  RCB1677     JHUEM-7     Human uterus endometrial adenocarcinoma cell line. Application consideration  
  RCB1558     JHUS-nk1     Human uterus squamous cell carcinoma cell line. Application consideration  
  RCB2651     JLS-V9     Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).  
  RCB2896     JLS-V9 6TG     Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350 (Deposited from Tohoku Univ.).  
  RCB3515     JLS-V9 BudR     Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356 (Deposited from Tohoku Univ.).  
  RCB0537     JM     Buck-up culture of ECA86010201. . Human T cell line with the ability to grow HIV, the same patient as Jurkat.  
  RCB2227     JMSU1     Human cell line derived from urinary bladder carcinoma. Derived from ascites.  
  RCB0456     JTC-12     Cynomolgus monkey cell line. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1485     JTC-12     Cynomolgus monkey cell line. Possible to culture in DMEM medium. See RCB0456. ワシントン条約対象。  
  RCB1461     JTC-15     Subclone of AH-66, lost transplantability in rats. Possible to culture in DMEM medium. See RCB0063.  
  RCB0063     JTC-15     Subclone of AH-66, lost transplantability in rats.  
  RCB0074     JTC-19     Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.  
  RCB1486     JTC-19     Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .  
  RCB1479     JTC-27     Ascites hepatoma. Possible to culture in DMEM medium. See RCB0065.  
  RCB0065     JTC-27     Ascites hepatoma.  
  RCB2686     JTC-35     Bovine granulosa cell line.  
  RCB1873     JTK-LCL     Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).  
  RCB0806     Jurkat     Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.  
  RCB3052     Jurkat     Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).  
  RCB0526     Jyg-MC(A)     murine mammary tumor cell lines. High level MMTV producer line.  
  RCB0527     Jyg-MC(B)     Murine mammary tumor cell lines. .Higher incidence in lung metastasis.  
  RCB0559     K-1.fl     SFFV producing Friend leukemia cell line. Non-differentiating.  
  RCB2859     K-251     Rat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).  
  RCB1635     K-562     Human CML derived cell line. Deposited directly from the institution that has established this cell.  
  HPS0062     K10M5     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0072     K11PD17     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0073     K21S4     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0074     K31M28     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0075     K32M17     Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  RCB1897     K562     Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes. TKG0210 (Deposited from Tohoku Univ.).  
  RCB0027     K562     Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .  
  RCB1898     K562/Adr     Subline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).  
  RCB0474     K562/MTX-2     Methotrexate(MTX)-resistant K562 cell line  
  RCB2111     K562/Vin     Subline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).  
  RCB2724     KB-D8     Rat cell line derived from dendritic cell carcinoma in thymus.  
  RCB1434     KE-39     Human cell line derived from gastric cancer  
  RCB1435     KE-97     Human cell line derived from intraperitoneal metastasis of gastric cancer  
  RCB2726     KE-F11     Rat cell line derived from malignant schwannoma.  
  RCB1166     KG-1     Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+  
  RCB0270     KG-1-C     Glioma, S-100 Protein producing. Cell growth is slow.  
  RCB1928     KG-1a     Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).  
  RCB1154     KGN     Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.  
  RCB2725     KJ-A     Rat cell line derived from malignant fibrous histiocytoma.  
  RCB1601     KKB     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1597     KKC     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1600     KKF     Mouse T cell line transformed by Gross leukemia virus.  
  RCB2138     KLM-1     Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).  
  RCB2623     KLN205     Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).  
  RCB2614     KLN205-MUC1     Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).  
  RCB0193     KMM-1     Human myeloma. Lambda- chain producing.  
  RCB1955     KMST-6     Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).  
  RCB1754     KMY-1     Subline of KMY-J. Fibroblast-like  
  RCB1755     KMY-2     Subline of KMY-J. Epithelial-like  
  RCB1756     KMY-3     Subline of KMY-J. Polyploidy  
  RCB1753     KMY-J     Meningioma derived cell line. Derived from rat F344.  
  RCB1874     KOIA-LCL     EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).  
  RCB2148     KOP     Mouse fibroblast-like cell line lacking p38 MAP kinase expression.  
  RCB0687     KP-N-NS     Adrenal neuroblastoma derived from brain metastasis  
  RCB1005     KP4     Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.  
  RCB1006     KP4-1     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB1007     KP4-2     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB1008     KP4-3     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB2367     KT01     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.  
  RCB2368     KT02     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.  
  RCB2369     KT03     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.  
  RCB2372     KT06     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.  
  RCB2375     KT09     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  
  RCB2376     KT10     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  
  RCB2377     KT11     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  
  RCB2378     KT12     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  
  RCB2379     KT13     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.  
  RCB2380     KT14     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.  
  RCB2381     KT16     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  
  RCB2382     KT17     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  
  RCB2383     KT18     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  
  RCB2386     KT21     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.  
  RCB2388     KT23     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.  
  RCB2389     KT26     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.  
  RCB2390     KT27     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.  
  RCB2392     KT29     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.  
  RCB2393     KT30     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.  
  RCB2395     KT32     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.  
  RCB2400     KT54     Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.  
  RCB0417     KU-1     Bovine B cell leukemia without virus production  
  RCB0418     KU-17     Bovine leukemia virus producing. Surface Ig (+). Application consideration  
  RCB1317     KU-SN     Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.  
  RCB0495     KU812     Chronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.  
  RCB0496     KU812E     Chronic myelogenous leukemia , subclone of RCB0495 KU812.  
  RCB0497     KU812F     Chronic myelogeneous leukemia, subclone of RCB0495 KU812.  
  RCB2295     KUM10     Mouse mesenchymal cell line derived from bone marrow. C57/B6.  
  RCB2147     KUM3     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB2112     KUM4     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB2322     KUM5     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB2113     KUM6     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB2114     KUM7     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB2115     KUM9     Mouse mesenchymal cell line derived from bone marrow. C3H/He  
  RCB4627     KUP5     An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution).  
  RCB2081     KUSA-A1     Mesenchymal stem cell line derived from C3H/He mouse strain.  
  RCB1990     KUSA-H1     Mouse bone marrow-derived stromal cells.  
  RCB1991     KUSA-O     Mouse multipotent mesenchymal cells. Derived from bone marrow.  
  RCB2088     Kato III     Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).  
  HES0001     KhES-1     Human embryonic stem cell line.  
  HES0002     KhES-2     Human embryonic stem cell line.  
  HES0003     KhES-3     Human embryonic stem cell line.  
  HES0004     KhES-4     Human embryonic stem cell line.  
  HES0005     KhES-5     Human embryonic stem cell line.  
  RCB0101     L·P3     Protein- & lipid-free medium growing  
  RCB2834     L12.9-2(1)     Human immortalized cell line derived from MRC5 cells.  
  RCB2844     L1210 TGR4     Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).  
  RCB2845     L1210-5FU-R-TC     Mouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).  
  RCB2833     L23immo     Human immortalized cell line derived from MRC5 cells.  
  RCB0135     L5178Y     Rapidly growing lymphoma  
  RCB1422     L929     TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.  
  RCB1451     L929     Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.  
  RCB2619     L929     Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).  
  RCB0483     LA-N-1     Neuroblastoma. N-myc gene amplification.  
  RCB0484     LA-N-2     Neuroblastoma. N-myc gene amplification.  
  RCB0485     LA-N-5     Neuroblastoma. N-myc gene amplification.  
  RCB2319     LACF-NaNaI     Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2320     LACF-NaNaII     Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2758     LAG     Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).  
  RCB2846     LAG-MUC1     A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).  
  RCB0455     LC-1/sq     Lung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F. Cell growth is slow.  
  RCB0438     LC-1/sq-SF     Lung Cancer-1/squamous (RCB0455 LC-1/sq), serum-free cultured. Application consideration  
  RCB0439     LC-1F     Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.  
  RCB0440     LC-2/ad     Adenocarcinoma, moderately differentiated. Cell growth is slow. Application consideration  
  RCB1425     LCAM1     Human lung cancer derived cell.  
  RCB1970     LK-2     Human lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).  
  RCB0558     LLC     Highly metastatic and drug-resistant mouse tumor. Application consideration  
  RCB0871     LLC-GA5-CoL150     Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.  
  RCB0872     LLC-GA5-CoL300     Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.  
  RCB1450     LM8     A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).  
  RCB1062     LMSU     Human cell line derived from lymph node metastasis of gastric cancer.  
  RCB2144     LNCap.FGC     Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603 (Deposited from Tohoku Univ.).  
  RCB0120     LT4Tr     Spontaneous transformant of LT4  
  RCB0208     LTK-     Thymidine kinase defective L cell  
  RCB1967     LU65     Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).  
  RCB0138     LX830     Highly sensitive to X-ray irradiation  
  RCB2910     LY-6-TC     Rat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).  
  RCB1869     LY-A     Subline of CHO-K1 cell line in which trafficking of ceramide is deficient  
  RCB1870     LY-A/hCERT     Subline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered  
  RCB1698     LY-B     Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.  
  RCB1699     LY-B/cLCB1     LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.  
  RCB2728     LY-H12     Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2729     LY-PPB6     Rat cell line derived from malignant peripheral nerve sheath tumor.  
  RCB1473     LYM-1     Sticky cell from lymph node. Possible to culture in DMEM medium.  
  RCB0076     LYM-1     Sticky cell from lymph node.  
  RCB1941     Li-7     Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing. TKG0368 (Deposited from Tohoku Univ.).  
  RCB1639     LoVo     CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.  
  RCB0466     Lu-134-A     Small cell carcinoma, classic type. See Lu-134-B. Application consideration  
  RCB0467     Lu-134-B     Small cell carcinoma, classic type. See Lu-134-A. Application consideration  
  RCB0468     Lu-135     Small cell carcinoma, variant type. Application consideration  
  RCB1785     Lu-138     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB0469     Lu-139     Small cell carcinoma, classic type. Application consideration  
  RCB0470     Lu-140     Small cell carcimoma, classic type. Application consideration  
  RCB1772     Lu-141     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB1773     Lu-143     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB1184     Lu-165     Producing high level of anti-diuretic hormone. Application consideration  
  RCB1771     Lu-24     Human cell line derived from lung cancer. Oat cell type. Application consideration  
  RCB1900     Lu99     Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).  
  RCB1971     Lu99B     Human lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).  
  RCB1471     Lyn^(-) DT40     Lyn deficient DT40 cells  
  RCB1500     Lyn^(-)/Syk^(-) DT40     Lyn and Sky deficient DT40 cells  
  RCB0067     M     Capable to form collagen network  
  RCB1472     M     Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.  
  RCB2534     M-MOK     Human cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).  
  RCB0169     M1     Differentiate to macrophage and granulocyte  
  RCB2621     M1(D+)     Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).  
  RCB0136     M10     Highly sensitive to X-ray irradiation  
  RCB0137     M10^(-)     Resistant to 6TG, isolated from M10  
  RCB0012     M227     Infected with ts mutant of Kirsten sarcoma virus  
  RCB1611     M4     Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.  
  RCB0994     MA104     Highly susceptible to Simian rotavirus SA11. Backup of ECA8510291 . Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2712     MAEC     Mouse cell line derived from aorta of p53-deficient mouse. Epithelial like.  
  RCB4489     MB86     Hybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.  
  RCB1444     MBHL-2     Insect cell line derived from Mamestra brassicae. Cell growth is slow.  
  RCB1445     MBHL-3     Insect cell line derived from Mamestra brassicae  
  RCB0544     MBT-2     Murine transitional cell carcinoma induced by FANFT  
  RCB0482     MC-NB-1     Neuroblastoma. N-myc gene amplicon analysis. Application consideration  
  RCB1126     MC3T3-E1     Differentiate to osteoblasts. Collagen producing.  
  RCB1127     MC3T3-G2/PA6     Support hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.  
  RCB1904     MCF7     Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).  
  RCB1192     MDA-MB-453     Human breast carcinoma established from an effusion. Application consideration  
  RCB0180     MDBK     Kidney epithelial cell, equiv. to ATCC CRL6071  
  RCB1859     MDBK-NST     Bovine kidney-derived epithelial cell line. FBS independent for culture.  
  RCB0995     MDCK     Canine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903 .  
  RCB2611     MDCK-AD     Dog cell line derived from kidney.  
  RCB2106     ME-180     Human cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).  
  RCB1027     MEB4     Not expressing melanoma antigen. Control for GM-95 cell line.  
  RCB2692     MEDEP-BRC4-1     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.  
  RCB2932     MEDEP-BRC4-2     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.  
  RCB2911     MEDEP-BRC5     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.  
  RCB2660     MEDEP-E14     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.  
  RCB2691     MEDEP-E14 clone 4     A subclone of MEDEP-E14(RCB2660) following cloning procedure.  
  RCB2694     MEDMC-BRC6     Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.  
  RCB2693     MEDMC-NT2     Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.  
  RCB0410     MEN1RGB     Fibroblasts from multiple endocrine neoplasia  
  RCB0421     MEN2RGB     Fibroblasts from multiple endocrine neoplasia  
  RCB0749     MFH-ino     Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.  
  RCB1890     MG-63     Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).  
  RCB2403     MG6     Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.  
  RCB1512     MH7A     Rheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.  
  RCB2094     MIA Paca2     Human cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).  
  RCB2305     MIH5(GIT)     Hybridoma producing a monoclonal antibody against mouse B7-H1.  
  RCB2324     MIH5(RPMI)     Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.  
  RCB3687     MKN-7     Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).  
  RCB1003     MKN1     Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.  
  RCB1001     MKN45     Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.  
  RCB0999     MKN7     c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.  
  RCB1002     MKN74     Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.  
  RCB1534     MLC-1-B     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  
  RCB1535     MLC-2-4     Bone marrow stroma cell line, depositing calcified matrix on the culture surface.  
  RCB1536     MLC-6     Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.  
  RCB1537     MLC-7     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  
  RCB2633     MM46 CEA1-2     Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).  
  RCB2634     MM46-APR-MUC1 cl.1     Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).  
  RCB0808     MMAc     Human melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.  
  RCB1200     MMAc·SF     Serum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit  
  RCB4561     MOLT-17     Human cell line derived from T cell leukemia (T-ALL). ACC 36 (Deposited from DMSZ.).  
  RCB1164     MOLT-3     Human T cell leukemia, the same patient as RCB0206 MOLT-4.  
  RCB0206     MOLT-4     T cell leukemia, the same patient as RCB1164 MOLT-3.  
  RCB1936     MOLT-4F     Human T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).  
  RCB3007     MOPC-70A     Mouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).  
  RCB0504     MR1-3     MNNG-reistant HeLa.S3(Mer~) cells  
  RCB0507     MR10-1     MNNG-resistant HeLa.S3(Mer~) cells  
  RCB0505     MR6     MNNG-resistant HeLa.S3(Mer~) cells  
  RCB0211     MRC-5     Normal embryonic lung fibroblast.  
  RCB0207     MRC-5 SV1 TG1     SV40-transformed, 6TG-resistant and HAT-sensitive.  
  RCB0218     MRC-5, known PDL     Normal embryonic lung fibroblast with accurate PDL  
  RCB2860     MRMT-1     Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).  
  RCB0725     MS-1     Small lung carcinoma. PTHrP producing.  
  RCB4680     MS-5     Mouse stromal cell line which supports hematopoietic cells.  
  RCB4681     MS-K     Murine cell line derived from sarcoma.  
  RCB1853     MSH6-1-[ClX3.16]DT40     A subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).  
  RCB2806     MSK-C5.8G     Rat cell line derived from osteosarcoma. F344 strain.  
  RCB2719     MT-10     Rat cell line derived from fibrous histiocytoma. After cloning.  
  RCB2722     MT-10R     A subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB0432     MT-5     MNNG-initiated clone of BALB/3T3 clone A31  
  RCB2718     MT-7     Rat cell line derived from fibrous histiocytoma. After cloning.  
  RCB0760     MT-8     Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.  
  RCB0762     MT-9     Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.  
  RCB2723     MT-PR     A subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. The parent cell line, MT-P, is also deposited but not available yet.  
  RCB2720     MT-R8     A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB2721     MT-R9     A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB0738     MTHC-1     Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.  
  RCB0739     MTHC-2     Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.  
  RCB0740     MTHC-3     Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.  
  RCB2642     MUSS     Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497 (Deposited from Tohoku Univ.).  
  RCB1837     MVP1     Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  
  RCB1838     MVP25     Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  
  RCB1839     MVP47     Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  
  RCB1840     MVP49     Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  
  RCB1841     MVP51     Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  
  RCB1701     MY     Human cell line derived from p180-BCR-ABL dependent leukemia.  
  RCB1487     MY-EBV-LCL     B95-8 EB virus transformed (originally normal) B cell line.  
  AES0197     Mili-KO GS     Mouse germline stem (GS) cell lacking Mili gene.  
  RCB1833     Mink     Lung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.  
  RCB0748     Mm1     Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.  
  RCB2766     Morris 5123D-TC     Rat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).  
  RCB1278     MtT/E     Estrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se. Application consideration.  
  RCB0528     MtT/S     Estrogen-induced tumor. Growth hormone producing. Application consideration.  
  RCB0530     MtT/SM     Growth hormone, prolactin producing. Application consideration.  
  RCB0529     MtT/Se     Estradiol-dependent pituitary tumor. Application consideration.  
  RCB1378     MuSS     A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.  
  RCB0996     Mv.1.Lu(NBL-7)     Aleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses.Back up culture of ECA88050503 .  
  AES0196     Mvh-Venus GS     This GS cell line was derived from testis of new born transgenic mouse, Tg(Mvh-Venus)1Rbrc, carrying Venus gene inserted into the 2nd exon of Mouse Vasa Homolog (Mvh or alternatively called Ddx4) gene. Mvh gene is known to be specifically expressed in male and female germ cells.  
  RCB2863     N14.5     Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  
  RCB1933     NALM-6     Human cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).  
  AES0190     NAT1(+/-)ES(A7)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  
  AES0191     NAT1(+/-)ES(B4)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  
  AES0192     NAT1(+/-)ES(C1)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  
  AES0194     NAT1(-/-)ES(B12)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  
  AES0193     NAT1(-/-)ES(B2)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  
  AES0195     NAT1(-/-)ES(C3)     Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  
  RCB1953     NB-1     Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486 (Deposited from Tohoku Univ.).  
  RCB0478     NB16     Neuroblastoma. N-myc gene amplification.  
  RCB0222     NB1RGB     Normal human skin fibroblast, RCB original  
  RCB2639     NB2a     Mouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).  
  RCB0480     NB69     Neuroblastoma. N-myc gene unamplified tumor. Cell growth is slow. Application consideration  
  RCB0477     NB9     Neuroblastoma ( Another name : CHP-212, PMID: 6871857 ) . N-myc gene amplification. Application consideration  
  RCB1371     NBT-L1     A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1372     NBT-L2a     A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1373     NBT-L2b     A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1369     NBT-T1     A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.  
  RCB1370     NBT-T2     A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.  
  RCB0803     NBsusSR     Isolated from a patient with hiper dopaminemia andnorepinephrinemia.  
  RCB3008     NC37     HGPRT(-), resistant to ouabain, partner cells for human B hybridoma. Ig nonproducer, human B lymphoblastoid cell line. This line and Raji(TKG0371)are derived from the same individual. TKG0232 (Deposited from Tohoku Univ.).  
  RCB2223     NCC-OvC-K119     Human cell line derived from ovarian cancer.  
  RCB2205     NCC-RbC-39     Human retinoblastoma cell line.  
  RCB2206     NCC-RbC-51     Human retinoblastoma cell line derived from cervical lymph node metastasis.  
  RCB2208     NCC-RbC-54     Human cell line derived from retinoblastoma.  
  RCB2212     NCC-RbC-59     Human cell line derived from retinoblastoma. Cell growth is slow.  
  RCB2213     NCC-RbC-60     Human cell line derived from retinoblastoma.  
  RCB2214     NCC-RbC-67     Human cell line derived from retinoblastoma.  
  RCB2217     NCC-RbC-83     Human cell line derived from retinoblastoma.  
  RCB2218     NCC-RbC-92     Human cell line derived from retinoblastoma.  
  RCB2219     NCC-RbC-T1     Human cell line derived from retinoblastoma.  
  RCB2224     NCC-StC-K140     Human cell line derived from stomach cancer.  
  RCB1598     NCKA     Mouse T cell line transformed by Gross leukemia virus.  
  RCB2341     NCR-G1     Human cell line derived from embryonal carcinoma of testis.  
  RCB2342     NCR-G2     Human cell line derived from embryonal carcinoma of testis.  
  RCB2343     NCR-G3     Human cell line derived from embryonal carcinoma of testis.Application consideration  
  RCB2344     NCR-G4     Human cell line derived from embryonal carcinoma of testis.  
  RCB0388     NCU-F1     Ehlers-Danlos syndrome  
  RCB0397     NCU-F10     Cockayne's syndrome  
  RCB0389     NCU-F2     Morquio syndrome  
  RCB0390     NCU-F3     Wilson's disease  
  RCB0391     NCU-F4     Wilson's disease  
  RCB0393     NCU-F6     Citrullinemia  
  RCB0394     NCU-F7     Citrullinemia  
  RCB0395     NCU-F8     Wilson's disease  
  RCB0490     NEC14     Embryonal carcinoma, testis. Application consideration  
  RCB0494     NEC15     Embryonal carcinoma, testis. Application consideration  
  RCB0489     NEC8     Embryonal carcinoma, testis.  
  RCB0282     NFSa Y83     In vivo transplantable highly metastatic sarcoma  
  RCB0359     NG-3Y1-D303     3Y1 transformed with nitrosoguanidine  
  RCB0371     NG-3Y1-T18D     3Y1 transformed with nitrosoguanidine  
  RCB2040     NGR50     Hybridoma producing a monoclonal antibody against SGPG.  
  RCB2037     NGR54     Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.  
  RCB2108     NH-12     Human cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).  
  RCB2109     NH-6     Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).  
  RCB1741     NHOS     Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.  
  RCB0162     NHSF46     Diploid fibroblast from normal Japanese skin.  
  RCB0405     NIAS-LeSe-11     Susceptible to insect viruses.  
  RCB0278     NIAS-MB-25     Show finely branched cytoplasmic processes  
  RCB0413     NIAS-MB-32     Show finely branched cytoplasmic processes. Application consideration  
  RCB0279     NIAS-MaBr-92     Susceptible to nuclear polyhedrosis virus  
  RCB0414     NIAS-MaBr-93     larval hemocyte  
  RCB0556     NIAS-PX-58     Pupal ovary hemocyte.  
  RCB0412     NIAS-PX-64     Pupal ovary hemocyte.  
  RCB2767     NIH/3T3     Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).  
  RCB1862     NIH3T3-3-4     Subclone of NIH3T3  
  RCB0057     NIH3T3/13C7     SV40 large T (tsA58)-pBR322 transformed NIH3T3.  
  RCB0056     NIH3T3/14-1     Spontaneous transformant of NIH3T3  
  RCB2135     NIH:OVCAR-3     Human cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).  
  RCB0733     NLS-6-5     Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.  
  RCB2346     NMFH-1     Human cell line derived from myxofibrosarcoma.  
  RCB2039     NMR52     Hybridoma producing a monoclonal antibody against nLc4Cer.  
  RCB2347     NMS-2     Human cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2813     NMuMG/Fucci     A subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.  
  RCB2868     NMuMG/Fucci2     A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5.Important notice regarding nomenclature of Fucci.  
  AES0118     NOD·ESA     Mouse embryonic stem (ES) cell line derived from NOD mouse.  
  RCB1032     NOS-1     Osteoid producing in vitro and in nude mice. Cell growth is slow.  
  RCB2348     NOS-10     Human cell line derived from osteosarcoma.  
  RCB1033     NOS-2     Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.  
  RCB4498     NP 2     Human cell line derived from anaplastic glioma.  
  RCB4504     NP 3     Human cell line derived from anaplastic glioma.  
  RCB4505     NP 5     Human cell line derived from anaplastic glioma.  
  RCB1921     NRG     Mouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.  
  RCB0043     NRK     Contact-inhibited semi-normal, original of NRK49F  
  RCB0112     NRK49F     Contact-inhibited semi-normal cell line  
  RCB1188     NRS-1     Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration  
  RCB0213     NS0     Myeloma. Application consideration  
  RCB1939     NUGC-4     Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).  
  AES0121     Nanog^(βgeo/+)ES     A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse). Nanog gene was replaced with βgeo gene in one allele.  
  AES0126     Nanog^(βgeo/Hyg)     A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse) lacking Nanog expression. Nanog genes were replaced with βgeo gene in one allele and hygromycin resistant gene in another allele. Feeder-free cell line.  
  RCB0245     Nil1C1     Highly metastatic sarcoma, synthesize hematoside  
  RCB0244     Nil2C1     Highly metastatic sarcoma  
  RCB0243     Nil2C2     Highly metastatic sarcoma  
  HPS0223     Nips-B2     Human iPS cell line. iPS cells were created using the Sendai virus vector. Past history : atopic asthma. Order Form(C-0042, C-0007 or C-0007p).  
  AES0152     OCRG9     Mouse embryonic stem cell line derived from 129/Ola.  
  RCB0882     OCUB-F     Same as OCUB-1, OCUB-M. Chromosome = pseudodiploid  
  RCB0881     OCUB-M     Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.  
  RCB2351     OGU1     Human cell line derived from primary effusion lymphoma (PEL). Application consideration  
  RCB0545     OHTA     Mouse embryonic carcinoma  
  RCB1290     OIH-1     Human myeloid leukemia cell line with chromosome 18 trisomy and mutation in DCC gene. Cell growth is slow. Application consideration  
  AES0050     OKM-4     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from ICR hermaphrodite mouse. Feeder-free cell line.  
  AES0154     OLC2-1     Mouse embryonic stem (ES) cell line derived from 129/Ola. The expression of Oct3/4 can be detected as the expression of ECFP.  
  RCB2946     OLCAB-e3     Medaka cell line derived from HB32 strain.  
  RCB2944     OLCAB-e31     Medaka cell line derived from HB32 strain.  
  RCB0184     OLF-136     Fish (medaka) fin fibroblast. Application consideration  
  RCB0187     OLHE-131     H04C medaka hepatoma pretreated with MAM-acetate. Application consideration  
  RCB2942     OLHNI-2     Medaka cell line derived from HNI strain.  
  RCB2943     OLHdrR-e3     Medaka cell line derived from HdrR strain.  
  RCB0188     OLME-104     HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Cell growth is slow. Application consideration  
  RCB2864     OLP6     Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  
  AES0153     OLV2-1     Mouse embryonic stem (ES) cell line derived from 129/Ola. The expression of Oct3/4 can be detected as the expression of Venus.  
  RCB2048     OMB4     Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.  
  RCB0753     OMC-1     Japanese cervix squamous cell carcinoma. Once said TA-4 positive.  
  RCB2830     OMC-2     Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.  
  RCB0755     OMC-3     Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.  
  RCB2832     OMC-9     Human cell line derived from endometrial stromal sarcoma.  
  RCB2049     OMR5     Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.  
  RCB2050     OMR6     Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.  
  RCB1124     OP9     Support hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.  
  RCB2924     OP9/G     Subline of OP9 cell line, expressing EGFP. Cell growth is slow. See RCB2117 TSt-4/G.  
  RCB2925     OP9/G-DLL1     Subline of OP9 cell line, expressing DLL1 and EGFP. Cell growth is slow. See RCB2118 TSt-4/G-DLL1.  
  RCB2926     OP9/N     Subline of OP9 cell line, expressing human NGF receptor. Cell growth is slow. See RCB2119 TSt-4/N.  
  RCB2927     OP9/N-DLL1     Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.  
  RCB0735     OS-RC-2     Renal tumor cell from a Japanese. Transplantable to nude mice.  
  RCB1593     OS3     ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes  
  RCB1926     OT11     RBP-J deficient mouse fibroblasts  
  RCB1927     OT13     Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)  
  RCB0492     OTCD1TKB     OTC(-), X-linked, dominant (XD)  
  RCB2848     OTT6050(B)     Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330 (Deposited from Tohoku Univ.).  
  RCB1483     OV2944-HM-1     Lymphnode-metastatic ovarian tumor. So called HM-1 cells.  
  RCB1903     OVK18     Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).  
  RCB2535     OVK18#102     Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).  
  RCB2808     Odf2-deficient F9 cells     A subline of mouse ES cell line, F9 (129), lacking Odf2.  
  RCB4499     Onda 10     Human cell line derived from anaplastic glioma.  
  RCB4500     Onda 11     Human cell line derived from glioblastoma.  
  RCB4518     Orai1^(-/-)DT40     A subline of avian cell line, DT40, lacking Orai1 gene.  
  RCB4519     Orai2^(-/-)DT40     A subline of avian cell line, DT40, lacking Orai2 gene.  
  RCB1167     P-815     Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays.  
  RCB1539     P19.CL6     Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.  
  RCB2318     P19.CL6     Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.  
  RCB1790     P19C6     Embryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.  
  RCB2815     P20.1     Hybridoma producing monoclonal antibody against a peptide, GYPGQV.  
  RCB1197     P2UR/K-562     Expressing P2U receptor acting in signal transduction pathway.  
  RCB0095     P3·NS-1/1·Ag4.1     Myeloma  
  RCB0146     P3-X63-Ag8.653     Myeloma  
  RCB1938     P30/OHK     Human cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).  
  RCB2776     P388     Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).  
  RCB2095     PANC-1     Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).  
  RCB0026     PAb1400     Anti-SV40 large T antigen mAb (IgG)  
  RCB0195     PAb419     Anti-SV40 large T antigen mAb (IgG)  
  RCB0009     PC-12     Pheochromocytoma, differentiate by NGF stimulation  
  RCB2145     PC-3     Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).  
  RCB4455     PC-9     Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)   
  RCB2800     PC12-F7     A subline of PC-12 lacking synaptotagmin-1.  
  RCB2801     PC12-G11     A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.  
  RCB2306     PC3.1     Hybridoma producing monoclonal antibody against latexin.  
  RCB1791     PCC3/A/1     Mouse teratoma-derived cell line.  
  RCB0673     PCH41-43     Hybridoma against differentiated PC-12 cell surface  
  RCB0674     PCH41-44     Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.  
  RCB0676     PCH42-58     Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.  
  RCB0669     PCH42-63     Hybridoma against differentiated PC-12 cell surface  
  RCB0678     PCH54-37     Hybridoma against differentiated PC-12 cell surface  
  RCB1460     PCM6     Human myeloma cell.  
  RCB1879     PEER     Human T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).  
  RCB1810     PI3Kp110α^(-) DT40     PI3Kp110α deficient DT40 cells  
  RCB1972     PK-1     Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239 (Deposited from Tohoku Univ.).  
  RCB1973     PK-45H     Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).  
  RCB2141     PK-45P     Human cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient. TKG0493 (Deposited from Tohoku Univ.).  
  RCB1901     PK-59     Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).  
  RCB2700     PK-8     Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).  
  RCB0534     PK15     Buck-up culture of ECA86103005. Pig kidney, susceptible to hog cholea, foot & mouth disease.  
  RCB2297     PKCβ^(-)DT40     Subline of DT40 cell line, lacking PKC-β expression.  
  RCB1469     PLC-γ2^(-) DT40     PLC-γ2 deficient DT40 cells  
  RCB1426     PMF-ko14     Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.  
  RCB1913     PST-S2     Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.  
  RCB4548     PT-r     Rat cell line derived from parathyroid gland.  
  RCB0538     PU5-18     Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501 .  
  RCB1560     PWS-Yamaguchi     Prader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.  
  RCB0350     Py-3Y1-S2     3Y1 transformed with mouse polyoma virus  
  RCB0688     QG-U     Japanese cervix carcinoma.  
  RCB2930     R4A9     Hybridoma cell line expressing a monoclonal antibidy against H-1 cells, a mouse bone marrow cell line. The target molecule in unknown  
  RCB1647     RAJI     Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.  
  RCB0535     RAW 264     Buck-up culture of ECA8510291 . Mouse leukemic monocyte. Abelson leukemia virus induced. Application consideration  
  RCB2782     RBL 2H3     Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).  
  RCB0782     RC4     Normal rabbit cornea cells. Usually transform spontaneously during serial culture.  
  RCB1151     RCC10RGB     Kidney carcinoma from a Japanese patient. Cell growth is slow.  
  RCB0511     RCN-9     Metastasis to liver, lung  
  RCB0512     RCN-H-4     Metastasis to liver  
  RCB1456     RCR-1     Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.  
  RCB0075     RCR-1     Astroglia cell line  
  RCB2695     RD-C2     Mouse osteoblast-like cell line derived from Runx2 deficient mouse.  
  RCB2696     RD-C6     Mouse osteoblast-like cell line derived from Runx2 deficient mouse.  
  RCB0165     REF-RGB     Suitable as feeders for hybridoma cloning  
  RCB0444     RERF-LC-AI     Japanese lung squamous carcinoma.  
  RCB1313     RERF-LC-KJ     Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.  
  RCB1556     RF/6A 135     Spont. transformant from choroid retina. Only slightly reactive to Factor VIII. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0163     RGB3T3-1     Original cloned line from RCB, just like BALB/3T3  
  RCB0164     RGB3T3-5     Siblings of RGB3T3-1, contact-inhibited  
  RCB2783     RGC-6     Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).  
  RCB0876     RGM1     So called clear cells from rat stomach mucosa.  
  RCB0183     RK13     Susceptible to rubella virus, equiv. to ATCC CCL37  
  RCB2149     RKOP     Subline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.  
  RCB0069     RLC-16     Epithelial cell from rat liver  
  RCB1474     RLC-16     Epithelial cell from rat liver. Possible to culture in DMEM medium.  
  RCB1484     RLC-18     Non tumorigenic in nude mice. Possible to culture in DMEM medium.  
  RCB0070     RLC-18     Non tumorigenic in nude mice  
  RCB1489     RLC-27     Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.  
  RCB0072     RLC-27     Liver-derived cell, tumorigenic in nude mice  
  RCB2784     RL♂1(Gloria)     Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).  
  RCB2299     RMC-1     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2303     RMC-11     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2304     RMC-17     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2300     RMC-2     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2301     RMC-3     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2302     RMC-6     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB1561     RML-Yoshi     Severe insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.  
  RCB1695     RMS-YM     Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.  
  RCB1878     RPMI1788     IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).  
  RCB3010     RPMI8226     Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).  
  RCB1025     RTH33     SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.  
  RCB2727     RY-B-E3     Rat cell line derived from endometrial stromal sarcoma.  
  RCB3673     Raji     Human cell line derived from Burkitt lymphoma. EBNA (EBV―nuclear antigen) positive. TKG0371 (Deposited from Tohoku Univ.).  
  RCB1830     Rat-1     Rat fibroblast-like cell line that can be transformed by oncogenes.  
  AES0145     Rx-GFP K/I EB5     A subline of mouse embryonic stem cell line, EB5 (129/Ola), in which GFP gene is knocked-in under Rx promoter.  
  RCB1834     S+L-Mink     Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.  
  RCB1966     S1     Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration  
  RCB2899     S180-Kumamoto-TC     Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).  
  RCB2900     S180-Meiji-TC     Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).  
  RCB2901     S180-NCC-TC     Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).  
  RCB2133     S2     Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration  
  RCB1153     S2 (Drosophila)     Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1.  
  RCB1974     SAS     Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).  
  RCB1829     SC-1     Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.  
  RCB3675     SCC-TC     Rectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).  
  RCB1952     SCCH-26     Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).  
  RCB0441     SCCKN     Highly sensitive to bleomycin  
  RCB3600     SDR-P-1D5     Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.  
  RCB3601     SDRL-1     Rat cell line derived from liver lacking growth hormone.  
  RCB3602     SDRL-2     Rat cell line derived from liver lacking growth hormone.  
  HES0006     SEES1     Human embryonic stem cell line.  
  HES0007     SEES2     Human embryonic stem cell line.  
  HES0008     SEES3     Human embryonic stem cell line.  
  RCB0275     SES-MaBr-1     Cabbage armyworm cell line applicable to large scale insect virus production.  
  RCB0276     SES-MaBr-3     Cabbage armyworm cell line applicable to large scaale production of insect virus.  
  RCB0404     SES-MaBr-4     Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.  
  RCB0429     SES-MaBr-5     Larval fat body hemocyte.  
  RCB0580     SF8402     Control from a nonexposed individual with breast cancer, different specimen from RCB0635  
  RCB0582     SF8404     Control from a nonexposed individual without cancer  
  RCB0583     SF8405     Control from a nonexposed individual without cancer.  
  RCB0584     SF8406     Control from a nonexposed individual without cancer.  
  RCB0635     SF8410     Control from a nonexposed individual with breast cancer, different specimen from RCB0580.  
  RCB0634     SF8413     Control from a nonexposed individual with chest cancer  
  RCB0633     SF8414     Control from a nonexposed individual with breast cancer  
  RCB0631     SF8416     Atomic bomb survivor with breast cancer  
  RCB0624     SF8425     Atomic bomb survivor with breast cancer, different specimen from RCB0621.  
  RCB0621     SF8428     Atomic bomb survivor with breast cancer, different specimen from RCB0624  
  RCB0620     SF8429     Atomic bomb survivor with breast cancer  
  RCB0617     SF8433     Atomic bomb survivor with breast cancer  
  RCB0614     SF8536     Atomic bomb survivor without cancer  
  RCB0610     SF8541     Control from a nonexposed individual with uterus cancer  
  RCB0608     SF8543     Control from a nonexposed individual with breast cancer  
  RCB0605     SF8546     Control from a nonexposed individual without cancer.  
  RCB0604     SF8647     Atomic bomb survivor with breast cancer.  
  RCB0603     SF8649     Atomic bomb survivor with breast cancer  
  RCB0602     SF8650     Atomic bomb survivor with breast cancer  
  RCB0600     SF8653     Atomic bomb survivor without breast cancer but with thyroid cancer.  
  RCB0598     SF8655     Atomic bomb survivor without cancer.  
  RCB0597     SF8656     Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.  
  RCB0585     SF8657     Control from a nonexposed individual with stomach cancer  
  RCB0596     SF8758     Atomic bomb survivor with breast cancer  
  RCB0587     SF8759     Atomic bomb survivor with breast cancer  
  RCB0588     SF8760     Atomic bomb survivor with breast cancer.  
  RCB0589     SF8761     Control from a nonexposed individual without cancer.  
  RCB0590     SF8762     Atomic bomb survivor with breast cancer.  
  RCB1940     SH-10-TC     Human cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).  
  RCB1465     SHIP^(-) DT40     SHIP deficient DT40 cells  
  RCB0453     SHOK     Contact-inhibited hamster embryonal cell line  
  RCB1466     SHP1^(-) DT40     SHP1 deficient DT40 cells  
  RCB1501     SHP1^(-)/SHP2^(-) DT40     SHP1 and SHP2 deficient DT40 cells  
  RCB1502     SHP2^(-) DT40     SHP2 deficient DT40 cells  
  RCB1792     SIL-6/1     Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.  
  RCB0426     SK-N-SH     Neuroblastoma, a target in CTL assay  
  RCB0685     SKG-II-SF     Large cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.  
  RCB1892     SKG-IIIa     Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).  
  RCB0513     SKN     Estradiol-17 beta responsive leiomyosarcoma  
  RCB1168     SKW-3     Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979  
  RCB2862     SLC     Rat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).  
  RCB1702     SLVL     Human cell line derived from splenic B cell lymphoma.  
  RCB1429     SN-512     Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.  
  RCB0209     SP2/0-Ag14     Myeloma  
  RCB1696     SPB-1     Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.  
  RCB1697     SPB-1/cLCB1     SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.  
  RCB0353     SR-3Y1-1     3Y1 transformed with Rous sarcoma virus  
  RCB0354     SR-3Y1-2     3Y1 transformed with Rous sarcoma virus  
  RCB1591     SRA 01/04     alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.  
  RCB1518     SS-A3-1     F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.  
  RCB1181     ST     A subclone of RCB1180 Tanoue.  
  RCB0224     ST2     Bone marrow stroma cell-derived  
  RCB2402     STIM1^(-)DT40     Subline of DT40 cell line, lacking STIM1 expression.  
  RCB4517     STIM1^(-/-)STIM2^(-/-)DT40     A subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.  
  RCB4516     STIM2^(-/-)DT40     A subline of avian cell line, DT40, lacking STIM2 gene.  
  RCB0536     STO     Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.  
  RCB0174     SUSM-1     Transformed in vitro with carcinogen  
  RCB0343     SV-3Y1-C66     3Y1 transformed with SV40 virion.  
  RCB0980     Sa3     Squamous carcinoma cells derived from human oral cancer.  
  RCB3688     Saos-2     Human cell line derived from osteogenic sarcoma cells. TKG0469 (Deposited from Tohoku Univ.).  
  RCB0428     Saos-2     Osteogenic sarcoma  
  RCB1152     Sawano     Naturally raised CDDP(cisplatin)-resistant cell line.  
  RCB1503     Shc^(-) DT40     Shc deficient DT40 cells  
  RCB1835     Sirc     Fibroblast-like cell line derived from rabbit.  
  RCB1868     Sos1^(-)/Sos2^(-)DT40     Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.  
  RCB1866     Sos1^(-)DT40     Subline of DT40 cell line, lacking Sos1 expression.  
  RCB1867     Sos2^(-)DT40     Subline of DT40 cell line, lacking Sos2 expression.  
  RCB1905     Sq-1     Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration  
  RCB0284     Sq-1979     Metastatic epithelial cell  
  RCB1470     Syk^(-) DT40     Syk deficient DT40 cells  
  RCB1861     T-23     Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0561     T-3-Cl-2-0.fl     Friend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl  
  RCB2307     T1.7     Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.  
  RCB1932     T2     Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).  
  RCB0431     T24     Bladder transitional-cell carcinoma  
  RCB2536     T24     Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).  
  RCB1017     T3M-1 Cl-10     G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.  
  RCB1015     T3M-1 Clone2     G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.  
  RCB1020     T3M-10     Lung large cell carcinoma producing CSF. Cell growth is slow.  
  RCB1022     T3M-11     Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.  
  RCB2281     T3M-12     Human lung small cell carcinoma cell line. ADH producing.  
  RCB1018     T3M-3     Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.  
  RCB1021     T3M-4     Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.  
  RCB1012     T3M-5     G-CSF producing thyroidal squamous carcinoma.  
  RCB0792     T88-M     IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell  
  RCB1954     T98G     Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).  
  RCB2298     TAK1^(-)DT40     Subline of DT40 cell line, lacking TAK1 expression.  
  RCB2084     TALL-1     Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).  
  RCB0443     TC-YIK     Integrating HPV16, neurosecretory granules(+)  
  AES0127     TCNT1     Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (T-cell) was derived from F1 (C57BL/6 x 129) male mouse.  
  RCB0689     TCO-2     Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).  
  RCB0638     TCS     Keratinizing cervix squamous carcinoma, CEA(+)  
  RCB1894     TE-1     Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).  
  RCB2099     TE-10     Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261 (Deposited from Tohoku Univ.).  
  RCB2100     TE-11     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).  
  RCB2101     TE-14     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).  
  RCB1951     TE-15     Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).  
  RCB2097     TE-4     Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0255 (Deposited from Tohoku Univ.).  
  RCB1949     TE-5     Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).  
  RCB1950     TE-6     Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).  
  RCB2098     TE-8     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).  
  RCB1988     TE-9     Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).  
  RCB1433     TEN     So called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).  
  RCB2537     TFK-1     Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).  
  RCB2203     TFS-2     Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.  
  RCB2204     TFS-4     Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.  
  RCB1148     TGBC11TKB     Japanese gastric cancer, lymph node metastated. Application consideration  
  RCB1186     TGBC14TKB     Japanese gallbladder tumor passed through a nude mouse. Application consideration  
  RCB1169     TGBC18TKB     Papillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow. Application consideration  
  RCB1129     TGBC1TKB     Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration  
  RCB1196     TGBC24TKB     Japanese gallbladder carcinoma established from metastated ascite. Application consideration  
  RCB1130     TGBC2TKB     Japanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration  
  RCB1280     TGBC50TKB     3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration  
  RCB1281     TGBC51TKB     3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration  
  RCB1282     TGBC52TKB     3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration  
  RCB1832     THK     SV40 transformed hamster cell line. Fibroblast-like cells.  
  RCB1189     THP-1     Differentates to macrophage-like cells after treatment with phorbol ester. The variant subline (RCB2128 A-THP-1). Application consideration  
  RCB3686     THP-1     Human cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).  
  RCB0752     TKD2     Kidney epithelial cells containing temperature sensitive SV40 large T antigen. Compared to TKC2.  
  RCB1907     TKKK     Human cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).  
  RCB1871     TL-1     Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607 (Deposited from Tohoku Univ.).  
  RCB1881     TL-Mor     Human derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).  
  RCB0750     TLR2     Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.  
  RCB1731     TM-31     Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)  
  RCB2107     TN-1     Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).  
  RCB1896     TN-2     Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).  
  RCB0481     TNB1     Neuroblastoma ( Another name : TGW, PMID: 2335222 ). N-myc gene amplification. Application consideration  
  RCB1125     TOM-2     Glassy cell carcinoma from cervix. Cell growth is slow.  
  AES2228     TPM2-187     The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_012060  
  AES2486     TPM5-123     The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_001081417  
  AES2641     TPM6-180     The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_177691  
  AES2764     TPM6-360     The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_010158  
  RCB1824     TRP1^(-) DT40     TRP1 deficient DT40  
  RCB2852     TSA8     Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370 (Deposited from Tohoku Univ.).  
  RCB0562     TSFAT-3.fl     Friend leukemia. Differentiate to erythroblastoid cells.  
  RCB2116     TSt-4     Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.  
  RCB2117     TSt-4/G     Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.  
  RCB2118     TSt-4/G-DLL1     Original murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.  
  RCB2119     TSt-4/N     Original murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.  
  RCB2120     TSt-4/N-DLL1     Original murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.  
  RCB4563     TSt-4/N-DLL4     Original murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.  
  RCB1185     TT1TKB     Rectal carcinoma from a Japanese patient. Cell growth is slow. Application consideration  
  AES0014     TT2     Mouse ES cell line (B6 X CBA). This cell line can be used only for in vitro culture experiment.  
  RCB1275     TUHR10TKB     Japanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.  
  RCB1383     TUHR14TKB     Japanese renal carcinoma cells. Cell growth is slow.  
  RCB1680     TUHR25TKB     Human cell line derived from kidney cancer.  
  RCB1187     TUHR3TKB     Japanese kidney carcinoma cells. RCB original. Cell growth is slow.  
  RCB1198     TUHR4TKB     Japanese renal carcinoma cells. Cell growth is slow.  
  RCB1438     TW-EBV-LCL     B95-8 EB virus transformed (originally normal) B cell line.  
  RCB1856     TX-7F (hybridoma)     Hybridoma producing a monoclonal antibody against tetrodotoxin.  
  RCB1180     Tanoue     B-lineage acute lymphoblastic leukemia.  
  RCB1692     Tpit/E     Immature pituitary cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse. PMID: 24881870  
  RCB1691     Tpit/F1     Folicular dendritic cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.  
  RCB1279     TtT/GF     Pituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.  
  RCB0531     TtT/M-87     Macrophage-like tumor dependent on L929 conditioned medium. Conditioned medium.  
  RCB0435     U-937 DE-4     Cloned U-937, differentiate with TNF  
  RCB2163     UE6E7-16     Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.  
  GMC0010     UN7RGB     Questionable Werner's syndrome-like. Life span in vitro was over 60 PDL.  
  GMC0011     UN8RGB     Once thought Werner's Syndrome, but the life span in vitro was more than 50 PDL.  
  RCB4451     UPS-1     Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).  
  RCB1998     UV·B6-2.1A     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB1999     UV·B6-4.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.  
  RCB2000     UV·B6-5.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  
  RCB1995     UV·BAL-1.1     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB2035     UV·BAL-17.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2057     UV·BAL-19.1A     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB1996     UV·BAL-2.1D     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB2024     UV·BAL-3.3     Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)  
  RCB2025     UV·BAL-5.4G     Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)  
  RCB2070     UV·CB6-5.2     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2074     UV·CC3-11.1     Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.  
  RCB1997     UV·B6-1.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  
  RCB2030     UV·BAL-12.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2031     UV·BAL-13.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2032     UV·BAL-14.2     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2033     UV·BAL-15.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2034     UV·BAL-16.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2036     UV·BAL-18.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2058     UV·BAL-20.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2059     UV·BAL-21.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2060     UV·BAL-23.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2026     UV·BAL-6.1E     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2027     UV·BAL-7.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2028     UV·BAL-8.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2029     UV·BAL-8.1C     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2061     UV·C3B6-1.1     Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2062     UV·C3B6-1.1C     Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2053     UV·C3H-3.3     Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  
  RCB2056     UV·C3H-8.2     Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  
  RCB2066     UV·CB6-3.4B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2071     UV·CB6-5.2B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB1157     UV-P3U1-B8     Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.  
  RCB2065     UV•CB6-2.1F     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2067     UV•CB6-4.1D     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2068     UV•CB6-4.1F     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2072     UV•CB6-6.1     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2073     UV•CB6-6.1B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB1992     UV♂1d     Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  
  RCB1993     UV♀1A     Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  
  RCB1994     UV♀2     Mouse vascular endothelial cell line. Transformed by ultraviolet.  
  RCB2329     V-3     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.  
  RCB2335     V-E5     X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.  
  RCB2336     V-G8     A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.  
  RCB0381     V12S-3Y1-2     3Y1 transformed with adenovirus type 12 12S-E1A  
  RCB0384     V13S-3Y1-4     3Y1 transformed with adenovirus type 12 13S-E1A  
  RCB0008     V79     Chinese hamster lung fibroblast  
  RCB2332     V79-4     A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  
  RCB2337     V79B     A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  
  RCB0251     VA-13     SV40-transformed WI-38.  
  HPS0351     VCP-#1     Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0352 and HPS0353 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0352     VCP-#2     Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0353 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0353     VCP-#4     Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0352 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  RCB1963     VMRC-RCW     Human renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).  
  RCB1809     Vav3^(-) DT40     Vav3 deficient DT40 cells  
  RCB0001     Vero     No interferon production, best for vaccine product. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0272     Vero-317     Culturable in proein-free MEM supplemented with biotin. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0707     Verots S3     Expressing SV40 tsA58 large T antigen. Possible to culture in protein-free MEM. G418-resistant. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0706     Verots S3(SF)     Expressing SV40 tsA58 large T antigen. Verots S3 cultured in protein-free MEM. G418-resistant. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0252     W-V     SV40-transformed Werner's syndrome fibroblast  
  RCB2279     WA-hT     Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.  
  RCB1925     WA-mFib     Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.  
  RCB0035     WEHI-3     Secrete growth factors for hematpoietic stem cells  
  RCB2853     WEHI-3B     Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).  
  RCB2904     WEHI164R     Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).  
  RCB2905     WEHI164S     Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).  
  RCB2146     WERI-Rb-1     Human cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).  
  RCB0704     WI-38     The most famous normal human fibroblast. Obtained directly from L. Hayflick.  
  RCB0702     WI-38     The most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.  
  RCB0520     WR216     APRT(-) EB transformed B cell line  
  RCB0409     WS1TKB     Werner's syndrome, the same patient as RCB0433 WS1TKB2.  
  RCB0433     WS1TKB2     Werner's syndrome, the same patient as RCB0409 WS1TKB.  
  GMC0006     WS2RGB     Accelerated aging in vitro, Werner's syndrome  
  RCB0407     WS2TKB     Werner's syndrome  
  GMC0007     WS3RGB     Accelerated aging in vitro, Werner's syndrome.  
  GMC0009     WS6RGB     Werner's syndrome fibroblast  
  RCB2909     Walker256-TC     Rat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).  
  RCB1831     XC     Cell line for titration of murine leukemia virus.  
  RCB2286     XPL 17     Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).  
  RCB2539     XPL 19     Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).  
  RCB2287     XPL 20     Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).  
  RCB2540     XPL 24     Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).  
  RCB1875     XPL 5     Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).  
  RCB2331     XR-1     A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.  
  RCB2339     XR-V15B     A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  
  RCB2338     XR-V9B-4     A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  
  RCB1770     XRCC3+/--DT40     Subline of DT40 cell line, lacking XRCC3 only in one allele.  
  RCB0771     XTC-YF     Frog (Xenopus laevis) cell line derived from tadpole.  
  RCB0770     XTY     Frog (Xenopus laevis) cell line derived from subcutaneous tumor.  
  RCB0533     Y1     Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.  
  RCB1645     Y79     Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.  
  RCB1165     YAC-1     Natural killer cell-sensitive mouse lymphoma.  
  RCB2799     YAC-1     Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).  
  RCB2110     YKG1     Human cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).  
  RCB1549     YSCCC     Human cell line derived from cholangiocellular carcinoma. Cell growth is slow.  
  RCB2136     YST-1     Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).  
  RCB3577     Yamato-SS     Human cell line derived from synovial sarcoma.  
  AES0136     ZHBTc4     Mouse ES cell line derived from ZHTc6 and maintained by tetracycline(Tc)-regulatable Oct-3/4 transgene. Both of Oct-3/4 locus are disrupted by IRES-zeocin and IRES-BSD KO vectors. It should be cultured in the absence of tetraycline to maintain the undifferentiated state. See reference regarding more precise information.  
  AES0137     ZHTc6     Mouse ES cell line derived from 129/Ola. It should be cultured in the presence of tetracycline to maintain the undifferentiated state. See reference regarding more precise information.  
  RCB2151     ZKOP     Subline of KOP cell line. Zeocin-resistant.  
  AES0147     aBJ-2     Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  
  AES0148     aBJ-3     Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  
  AES0149     aBJ-4     Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  
  RCB1303     anti-αA-crystallin     Anti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1304     anti-αB-crystallin     Anti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1305     anti-β5-crystallin     Anti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1306     anti-β6-crystallin     Anti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1308     anti-δ-crystallin     Anti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1307     anti-γ1-crystallin     Anti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  
  RCB1509     clone 64     Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.  
  RCB1508     clone 76     Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.  
  RCB1506     clone YP1N25     Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible. Cell growth is slow.  
  RCB1507     clone YP1N27     A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.  
  RCB0347     dl-884-3Y1-KO1     3Y1 transformed with SV40 dl-884  
  RCB1924     h1c     Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  
  RCB3586     hPSC-1     Human cell line derived from choronic pancreatitis. Pancreatic stellate cells.  
  RCB3589     hPSC-14     Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  
  RCB3588     hPSC-5     Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  
  HPS0085     iCK10     Disease specific iPS cell line derived from a patient : Cockayne's syndrome(RCB0397 NCU-F10). HPS0083 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0083     iCK2     Disease specific iPS cell line derived from a patient : Cockayne's syndrome(RCB0397 NCU-F10). HPS0085 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0087     iOTC4     Disease specific iPS cell line derived from a patient : Ornithinetranscarbamylase deficiency (RCB0492 OTCD1TKB). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  APS0007     iPS-Hep-FB/Ng/gfp-103C-1     Mouse iPS cell line derived from liver cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. GFP and puromycin resistant gene can be expressed by Nanog promoter. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0008     iPS-L1     Rabbit induced pluripotent stem (iPS) cell line. Application consideration. Order Form ( C-0033, C-00007 or C-0007p).  
  APS0009     iPS-L2     Rabbit induced pluripotent stem (iPS) cell line. Order Form ( C-0033, C-00007 or C-0007p).  
  APS0003     iPS-MEF-Fb/Ng-440A-3     Mouse iPS cell line established without retrovirus vector. It has no integration of exogene. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0002     iPS-MEF-Ng-178B-5     Mouse iPS cell line established with three factors, Oct3/4, Sox2 and Klf4, using retrovirus vector. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0001     iPS-MEF-Ng-20D-17     Mouse induced pluripotent stem (iPS) cell line. Expressing GFP by Nanog promoter. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0004     iPS-MEF-Ng-492B-4     Mouse iPS cell line established without retrovirus vector. It has no integration of exogene. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0010     iPS-S1     Rabbit induced pluripotent stem (iPS) cell line. Application consideration. Order Form ( C-0033, C-00007 or C-0007p).  
  APS0011     iPS-S2     Rabbit induced pluripotent stem (iPS) cell line. Order Form ( C-0033, C-00007 or C-0007p).  
  APS0005     iPS-Stm-FB/gfp-99-1     Mouse iPS cell line derived from stomach cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  APS0006     iPS-Stm-FB/gfp-99-3     Mouse iPS cell line derived from stomach cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  
  HPS0288     iPS-WS2-C5     Disease specific iPS cell line derived from a patient : Werner syndrome. Order Form (C-0042, C-0057, C-0007).  
  HPS0082     iPWS5     Disease specific iPS cell line derived from a patient : Prader Willi syndrome(RCB1560 PWS-Yamaguchi). del(15) was found in lymphocytes of the patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0149     iTS1     Disease specific iPS cell line derived from a patient : Tay-Sachs' disease (RCB0697 GM2-1TKB). iPS cells were created using the Sendai virus vector. HPS0150 and HPS0151 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0150     iTS2     Disease specific iPS cell line derived from a patient : Tay-Sachs' disease (RCB0697 GM2-1TKB). iPS cells were created using the Sendai virus vector. HPS0149 and HPS0151 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  RCB0336     in203-3Y1-19     3Y1 transformed with adenovirus in203.  
  RCB0337     in203-3Y1-23     3Y1 transformed with adenovirus in203.  
  RCB0335     in203-3Y1-7     3Y1 transformed with adenovirus in203.  
  RCB2328     irs1SF     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.  
  AES0004     mGS-DBA1     Multipotent germline stem (mGS) cell line derived from mouse testis.  
  RCB0379     mos-3Y1-10     3Y1 transformed with v-mos oncogene  
  RCB0380     mos-3Y1-16     3Y1 transformed with v-mos oncogene  
  RCB4592     r/mHM-SFME-1     Comment.  
  AES0174     rdES2-1     Rabbit embryonic stem (ES) cell line.Application consideration  
  AES0175     rdES4     Rabbit embryonic stem cell line. Application consideration  
  RCB0286     tk^(-)ts13     Thymidine kinase-defective mutant of ts13  
  RCB1264     tsBN2     Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.  
  RCB1272     tsBN250     Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.  
  RCB1273     tsBN269     Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.  
  RCB1268     tsBN462     Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration  
  RCB1270     tsBN51     Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.  
  RCB1271     tsBN67     Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.  
  RCB1267     tsBN7     Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.  
  RCB1269     tsBN75     Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.  
  RCB1811     ΔBLM-DT40     Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.  
  RCB1814     ΔDinBΔXPA-DT40     Subline of DT40 cell line, lacking both of DinB and XPA expression.  
  RCB1633     ΔMre11ΔKu70-DT40     Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).  
  RCB1631     ΔRad51+hRad51-DT40     Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).  
  RCB1767     ΔRad52ΔXRCC3-DT40     Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.  
  RCB1812     ΔWRN-DT40     Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.  
  RCB1813     ΔWRNΔBLM-DT40     Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.  
  RCB1768     ΔXRCC3-cond1-DT40     Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.  
  RCB1769     ΔXRCC3-cond2-DT40     Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.  
  RCB1766     ΔligIV-DT40     Subline of DT40 cell line, lacking ligase IV expression.  
  RCB1117     ψCRE-MFGts-c-src     Producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.  
  RCB1119     ψCRE-MFGtsT     High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.  
  RCB1573     ψCRIP-ATR-bsr     Cell line producing retrovirus to express angiotensin receptor.  
  RCB1580     ψCRIP-MFG-T37     Cell line producing retrovirus to express SV40 large T antigen.  
  RCB1579     ψCRIP-MFG-Z     Cell line producing retrovirus to express lac Z.  
  RCB1116     ψCRIP-MFGHSVtk     Producer of MoMLV-derived retrovirus including HSV thymidine kinase cDNA.  
  RCB1104     ψCRIP-MFGhM-CSF     Producer of MoMLV-derived retrovirus including human M-CSF gene.  
  RCB1106     ψCRIP-MFGhMIF     Producer of MoMLV-derived retrovirus including human MIF cDNA.  
  RCB1109     ψCRIP-MFGhOncost-M     Producer of MoMLV-derived retrovirus including human oncostatin M cDNA.  
  RCB1101     ψCRIP-MFGhTNF-α     Producer of MoMLV-derived retrovirus including human TNF-alpha cDNA.  
  RCB1110     ψCRIP-MFGmB7     Producer of MoMLV-derived retrovirus including mouse B7 (CD80) cDNA.  
  RCB1111     ψCRIP-MFGmB7-2     Producer of MoMLV-derived retrovirus including mouse B7-2 (CD86) cDNA.  
  RCB1103     ψCRIP-MFGmG-CSF     Producer of MoMLV-derived retrovirus including mouse G-CSF gene.  
  RCB1089     ψCRIP-MFGmGM-CSF     Producer of MoMLV-derived retrovirus including mouse GM-CSF cDNA  
  RCB1105     ψCRIP-MFGmIFN-γ     High-titer producer of MoMLV-derived retrovirus including mouse IFN-gamma cDNA.  
  RCB1097     ψCRIP-MFGmIL-10     Producer of MoMLV-derived retrovirus including mouse IL-10 cDNA  
  RCB1099     ψCRIP-MFGmIL-12p35     Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p35 subunit. Refer RCB1098.  
  RCB1098     ψCRIP-MFGmIL-12p40     Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p40 subunit. Refer RCB1099.  
  RCB1091     ψCRIP-MFGmIL-1RA     High-titer producer of MoMLV-derived retrovirus including mouse IL-1 receptor antagonist cDNA  
  RCB1090     ψCRIP-MFGmIL-1α     High-titer producer of MoMLV-derived retrovirus including mouse IL-1alpha cDNA.  
  RCB1092     ψCRIP-MFGmIL-2     High-titer producer of MoMLV-derived retrovirus including mouse IL-2 cDNA  
  RCB1093     ψCRIP-MFGmIL-3     Producer of MoMLV-derived retrovirus including mouse IL-3 cDNA  
  RCB1094     ψCRIP-MFGmIL-4     Producer of MoMLV-derived retrovirus including mouse IL-4 cDNA  
  RCB1095     ψCRIP-MFGmIL-6     Producer of MoMLV-derived retrovirus including mouse IL-6 cDNA  
  RCB1096     ψCRIP-MFGmIL-7     Producer of MoMLV-derived retrovirus including mouse IL-7 cDNA  
  RCB1108     ψCRIP-MFGmKitLigand     Producer of MoMLV-derived retrovirus including mouse kit ligand (SCF) cDNA.  
  RCB1107     ψCRIP-MFGmLIF     Producer of MoMLV-derived retrovirus including mouse leukemia inhibitory factor cDNA.  
  RCB1102     ψCRIP-MFGmLT     Producer of MoMLV-derived retrovirus including mouse lymphotoxin cDNA.  
  RCB1100     ψCRIP-MFGmTNF-α     Producer of MoMLV-derived retrovirus including mouse TNF-alpha gene.  
  RCB1115     ψCRIP-MFGneo     Producer of MoMLV-derived retrovirus including neo gene.  
  RCB1113     ψCRIP-MFGrab-IL1RA     Producer of MoMLV-derived retrovirus including rabbit IL-1 receptor antagonist cDNA.  
  RCB1114     ψCRIP-MFGratGM-CSF     Producer of MoMLV-derived retrovirus including rat GM-CSF cDNA.  
  RCB1112     ψCRIP-MFGtrγIFNR     Producer of MoMLV-derived retrovirus including the trancated form of mouse IFN-gamma cDNA.  
  RCB1118     ψCRIP-MFGts-c-src     High-titer producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.  
  RCB1120     ψCRIP-MFGtsT     High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.  
  RCB1581     ψCRIP-MSHR     Cell line producing retrovirus to express human MSH receptor.  
  RCB1582     ψCRIP-NCre     Cell line producing retrovirus to express Cre recombinase.  
  RCB1088     ψCRIP-P131     High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.  
  RCB1576     ψCRIP-Rx-ETBR-bsr     Cell line producing retrovirus to express the human endothelin receptor.  
  RCB1575     ψCRIP-Rx-crmA-bsr     Cell line producing retrovirus to express the anti-apoptotic crmA.  
  RCB1584     ψCRIP-RxBcl-XL-i-bsr     Cell line producing retrovirus to express human Bcl-xL and blasticidin S deaminase gene.  
  RCB1574     ψCRIP-RxhCD82     Cell line producing retrovirus to express the human CD82.  
  RCB1585     ψCRIP-RxhFAS-i-CD80     Cell line producing retrovirus to express human FAS and human CD80.  
  RCB1587     ψCRIP-RxhSecR-bsr     Cell line producing retrovirus to express human secretin receptor and blasticidin S deaminase gene.  
  RCB1590     ψCRIP-RxhVIPR-bsr     Cell line producing retrovirus to express human VIP receptor and blasticidin S deaminase gene.  
  RCB1589     ψCRIP-RxmPCNT1-i-bsr     Cell line producing retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase gene.  
  RCB1564     ψCRIP-RxnZ     Subline of ψCRIP that produce virus to express LacZ possessing nuclear localization signal.  
  RCB1572     ψCRIP-hBax-i-hCD25-CS     Retrovirus producer. Produce virus to express human Bax protein.  
  RCB1588     ψCRIP-hSSR-bsr     Cell line producing retrovirus to express human somatostatin receptor and blasticidin S deaminase gene.  
  RCB1583     ψCRIP-hp53-bsr     Cell line producing retrovirus to express human p53 and blasticidin S deaminase gene.  
  RCB1577     ψCRIP-mPCNF1-bsr     Cell line producing retrovirus to express the mouse calcineurin.  
  HPS0256          Disease specific iPS cell line derived from a patient : Alzheimer disease. Order Form (C-0042, C-0057, C-0007).  
  HPS0336          Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0334 and HPS0335 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0546          Disease specific iPS cell line derived from a patient : Mucopolysaccharidosis (MPS)VI. Order Form (C-0042, C-0057, C-0007).  
  HPS0265          Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0266 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0078          Disease specific iPS cell line derived from a patient : Bernard-Soulier syndorome. Order Form (C-0042, C-0007 or C-0007p).  
  HPS0266          Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0265 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS1012          Disease specific iPS cell line derived from a patient :Best disease. Order Form (C-0042, C-0057, C-0007).  
  HPS0217          Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0215 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0407          Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. HPS1010 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  
  HPS0333          Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Order Form (C-0042, C-0057, C-0007).  
  HPS0156          Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0157 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0313          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0314 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0314          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0313 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0157          Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0156 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0525          Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta.  
  HPS0164          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0176          Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 2. HPS0175 and HPS0177 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0540          Disease specific iPS cell line derived from a patient :Muscular dystrophy, Myotonic Dystrophy.  
  HPS0169          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0171 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0939          Disease specific iPS cell line derived from a patient :Achondroplasia.  
  HPS0171          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0169 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0945          Disease specific iPS cell line derived from a patient :Osteogenesis Imperfecta.  
  HPS0174          Disease specific iPS cell line derived from a patient : Dermatomyositis (DM). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0183          Disease specific iPS cell line derived from a patient : Inclusion body myositis. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0489          Disease specific iPS cell line derived from a patient : Niemann-Pick disease, Type C variant biochemical phenotype. HPS0488 and HPS0490 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  
  HPS1725          Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Order Form (C-0042, C-0057, C-0007).  
  HPS1728          Disease specific iPS cell line derived from a patient : Epilepsy. Order Form (C-0042, C-0057, C-0007).  
  HPS0184          Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0185 and HPS0186 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0178          Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), HPS0180 was derived from the same patient. Systematic Sclerosis (SSc). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0317          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0319, HPS0322 and HPS0323 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0186          Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0184 and HPS0185 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0191          Disease specific iPS cell line derived from a patient : Bernard-Soulier syndrome. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0192          Disease specific iPS cell line derived from a patient : Allergic rhinitis (Pollen allergy). Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0207          Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0319          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0322 and HPS0323 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0209          Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0211 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0200          Disease specific iPS cell line derived from a patient :Muscular dystrophy, Limb-girdle type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0312          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0313 and HPS0314 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0214          Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, Kosho Type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0215          Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0217 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0224          Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0226 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0227          Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0228 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0233          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Becker type. HPS0234 was derived from the same patient.iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0240          Disease specific iPS cell line derived from a patient : Metachromatic leukodystrophy (MLD). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0332          Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Order Form (C-0042, C-0057, C-0007).  
  HPS0339          Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0338 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0338          Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0339 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0140          Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Familial type. HPS0141 and HPS0142 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0142          Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Familial type. HPS0140 and HPS0141 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0060          Disease specific iPS cell line derived from a patient : Dementia of Alzheimer’s type. HPS0812 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  
  HPS0059          Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  
  HPS0064          Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 1b. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0070          Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0071 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0071          Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0070 was derived from the same patient.iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0097          Disease specific iPS cell line derived from a patient : Parkinson's disease, Familial type, PARK2. Order Form (C-0042, C-0007 or C-0007p).  
  HPS1010          Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. HPS0407 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  
  HPS0953          Disease specific iPS cell line derived from a patient :Achondroplasia.  
  HPS1011          Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. Order Form (C-0042, C-0057, C-0007).  
  HPS1013          Disease specific iPS cell line derived from a patient :Gelatinous drop-like corneal dystrophy. Order Form (C-0042, C-0057, C-0007).  
  HPS1072          Disease specific iPS cell line derived from a patient :Age related Macular degeneration. Order Form (C-0042, C-0057, C-0007).  
  HPS0129          Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (classical, with UMN). HPS0130 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0130          Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (classical, with UMN). HPS0129 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
  HPS0133          Disease specific iPS cell line derived from a patient : Muscular dystrophy, Miyoshi type (Miyoshi myopathy). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  
&nbs